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Nitrochemicals are widely distributed throughout the environment from natural and 
human sources. They are present in rocket fuels, wastes from chemical industry, in the 
exhaust from internal combustion engines and tobacco smoke. They are also used as 
explosives, herbicides, pesticides, biocides and drugs. In addition, 3-nitro-tyrosine and 
other nitrated protein residues are important post-translational markers for oxidative 
damage, septic shock, Alzheimer’s disease as well as many cardiovascular, 
neurodegenerative and malignant conditions. Nitrated proteins, amino acids and 
metabolites often possess antibiotic activity and, consequently, can mitigate bacterial 
and/or fungal infection. Because of the wide presence of the nitrocompounds as toxins, 
potential nitrogen/carbon sources or metabolic intermediates, different organisms have 
evolved to produce enzymes that can biodegrade them. Nitroalkane oxidase (NAO) 
produced by Fusarium oxysporum, is one such enzyme.  
 
NAO catalyzes the oxidation of the neutral nitroalkanes to the corresponding 
aldehydes or ketones with production of H2O2 and nitrite. The enzyme is overexpressed 
when cultures of the fungus are grown on nitroethane as a sole source of nitrogen. The 
reasonable physiological roles for NAO include: a) that it protects the fungus from 
nitroalkanes produced by plants, b) to detoxify antibiotics produced by the competing soil 
microbes such as Pseudomonas fluorescens, and/or c) as a strategy to scavenge nitrogen 
from a variety of nitrochemicals. NAO is a unique flavoenzyme, which belongs to acyl-
CoA dehydrogenase (ACAD) superfamily but does not bind or turnover acyl-CoA 
substrates. The enzyme is also different from its ACAD homologs in following a 
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carbanion reaction mechanism. Interestingly, the resting state of the enzyme selectively 
reacts with neutral nitroalkanes but after a few steps into the catalytic cycle, the enzyme 
reacts with negatively charged nitroalkane species to form a stable covalent N5-FAD 
adduct. The adduct has been isolated and characterized as N5-(2-nitrobutyl)-1,5-dihydro-
FAD in case of nitroethane substrate.  
 
Most of the biochemical studies on NAO were performed by our collaborators (Dr. 
Fitzpatrick, Dr. Valley and Dr. Gadda) but the novel characteristics of the enzyme 
prompted us to initiate structural studies of the enzyme. X-ray diffraction methods along 
with the spectroscopic techniques were used to solve the three dimensional molecular 
structure of resting state (Eox), inhibited state (EI) and substrate trapped reaction 
intermediate (ES*) of NAO. The crystal structures of EI and ES* of NAO were solved to 
2.07 Å and 2.2 Å resolutions respectively.  
 
The homotetrameric structure of ES* was solved by MAD phasing with 52 Se-Met 
sites in an orthorhombic space group. The electron density for the N5-(2-nitrobutyl)-1,5-
dihydro-FAD covalent intermediate was clearly resolved. The structure of ES* was used 
to solve the crystal structure of EI, a complex with weak competitive inhibitor, spermine. 
The crystals of EI grew with a c axis of 485 Å and 1½ holoenzymes in the asymmetric 
unit, which made high resolution data collection very challenging. The structures of ES* 
and EI reveal a hydrophobic channel that extends from the exterior of the protein to the 
re-face of the FAD which terminates at the N5-FAD position. Both the structures also 
show that Asp402 is located at the end of the substrate access channel. Moreover, the 
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residue is in the correct position to serve as the active site base, where it is proposed to 
abstract the α-proton from neutral nitroalkane substrates. The protein fold for NAO and 
various members of the ACAD superfamily overlay with root mean square deviations 
between 1.7 to 3.1 Å. The homologous region typically spans more than 325 residues and 
includes Glu376, which is the active site base in the prototypical member of the ACAD 
family. However, NAO and the ACADs exhibit differences in substrate access channel, 
hydrogen bonding interactions between the respective active site base, substrate 
molecules and the FAD. These aspects differentiate NAO from its homologs and, 
therefore are proposed to result in the unique reaction mechanism of NAO.  
 
The crystal structures of NAO have given us structural insights into the reaction 
mechanism of this new member of ACAD superfamily. At the same time, these crystal 
structures also form the basis for directed evolution studies. It is likely that NAO and 
other ACAD superfamily members might have diverged from a common ancestor to 
perform different chemistries but retained an overall similar protein fold especially since 
Fusarium oxysporum has high mutation rate and a large variety of transposons. The 
molecular structure of NAO in conjunction with protein engineering techniques can also 
be used for designing biocatalysts for different substrates. Another interesting application 
of NAO can be in the field of biosensors. The enzyme has a versatile redox center, which 
can be modulated by the active site environment. The modified FAD can then serve as 
on-off or gradient switch in various bioelectronic applications.  
 
 




1.1 Nitrocompounds in Biosphere  
Nitrochemicals from natural and anthropomorphic sources are distributed 
throughout the environment. Organic nitro-compounds are often difficult to metabolize, 
mutagenic or toxic and consequently occur only rarely from natural sources. However, 
when they are biosynthesized they are often used as a chemical defense against pathogens 
(Clark et al., 1974; Hanawa et al., 2000). For example, 3-nitropropionic acid (3NPA), 
which is produced by some plants, is extremely toxic and inhibits succinate 
dehydrogenase and fumarase with very high affinity. Plants like Hippocrepis comosa 
produce 3NPA in extremely large quantities in their leaves, which serves as powerful 
chemical defense mechanism (Hipkin et al., 1999). The biocidal activity of 3NPA resides 
in part, by inhibition of the citric acid cycle of potential pathogens (Porter & Bright, 
1980; Hassel & Sonnewald, 1995). Recently, 3NPA has also been shown to induce 
oxidative stress in striatal and brain cortex synaptosomes in rats (Tunez et al., 2005).  
 
Another class of organic nitro-compounds is the antibiotics secreted by various 
prokaryotes and eukaryotes. Broad range antibiotics like chloramphenicol bind to 50S 
ribosomal unit and inhibit peptidyl transferase activity in bacteria (Marconi et al., 1990). 
Azomycin, a nitroheterocyclic antibiotic produced by Streptomyces and some strains of 
Pseudomonas is the basis for the most popular synthetic drug metronidazole (Osato et al., 
1955; Shoji et al., 1989). Apart from toxins and antibiotics, the toxicity of many 
nitrochemicals originates from their metabolic transformation.  The reduction of organic 
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nitrochemicals by one, two or four electrons produces nitro-radical anions, nitroso and 
hydroxylamino intermediates, respectively (Nathan & Shiloh, 2000).  These types of 
reactive nitrogen intermediates are strong mutagens similar to nitrous acid and 
hydroxylamine, which readily modify DNA bases. For example, nitroreduction of 
dehydrochloramphenicol (DH-CAP), a bacterial metabolite of chloramphenicol, by 
human bone marrow cells produces toxins that are the underlying cause of genotoxicity 
(Isildar et al., 1988). 
 
In addition, nitrated protein residues, such as 3-nitro-tyrosine (3-NO2-Tyr) are 
now important post-translational markers for oxidative damage, septic shock, 
Alzheimer’s disease as well as many cardiovascular, neurodegenerative and malignant 
conditions (Aulak et al., 2004; Irie et al., 2003; Schopfer et al., 2003; Turko & Murad, 
2002). Explosive compounds like nitroglycerin (TNG) and 2,4,6-trinitrotoluene (TNT) do 
not have any known naturally occurring counterparts; therefore, they are often considered 
xenobiotic (Spain, 1995; Spain et al., 2000; Rosser et al., 2001). 
 
1.2 Biotransformation of Nitrochemicals 
Recent studies have established that many nitrochemicals are catabolized by 
prokaryotic and eukaryotic organisms as sources of nitrogen and/or carbon (Spain, 1995; 
Spain et al., 2000; Rosser et al., 2001; French et al., 1998; Trott et al., 2003; Somerville 
et al., 1995; Ebert et al., 2001). Indeed, several prokaryotic, FMN-dependent enzymes 
have received recent attention because they reductively eliminate nitrite from xenobiotic 
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explosive compounds, which can serve as a sole sources of nitrogen (Spain, 1995; French 
et al., 1998; Johnson et al., 2002; Binks et al., 1996; Khan et al., 2002; Meah et al., 2001; 
Nivinskas et al., 2000; Williams et al., 2004). Enzymes like xenobiotic reductase A 
isolated from Pseudomonas putida II-B (XenA) and B from P. fluorescens I-C (XenB) 
catalyze NADPH-dependent reductive nitrite elimination from nitroglycerin. These 
strains not only tolerate concentrations of nitroglycerin that are toxic to nearly all other 
microbes, but they can also obtain all their nitrogen for growth from the xenobiotic 
compound (Blehert et al., 1997; Blehert et al., 1999). Thus it appears that the reductive 
enzymes enable some microorganisms to exploit nitrochemicals introduced into the 
environment by recent human activities.   
 
In contrast, several FAD-dependent, eukaryotic enzymes are known to catalyze 
oxidative nitrite eliminations from naturally occurring nitroaliphatic compounds 
(Dhawale, M. R. & Hornemann, U., 1979; Kido et al., 1976; Kido et al., 1976; Kido et 
al., 1978; Kido & Soda, 1978; Gadda et al., 2000; Gadda & Fitzpatrick, 1999).  The 
enzymes in this class appear to have evolved in parallel with nitrochemical biosynthesis 
pathways. Typically, the organisms that produce nitroalkane toxins such as 3-
nitropropionate, also produce enzymes that transform the nitroaliphatic internally, and 
thus protect the host from the toxic effects of the agent (Porter & Bright, 1987; Hipkin et 
al., 1999). In turn, some of the organisms targeted by the toxins also evolved strategies to 
detoxify various nitrocompounds (Lee et al., 2003).  
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1.3 Nitrite Elimination by Flavoenzyme Oxidases 
Flavoenzymes are a ubiquitous and diverse class of biological redox catalysts 
(Muller, 1991). The redox activity centers of these enzymes are derivatives of riboflavin 
(vitamin B2), which consists of an isoalloxazine ring system substituted with methyl 
groups at C7 and C8 and a ribityl group at N10 (Stankovich, 1991). The flavin redox 
center is chemically versatile and flavoenzymes can act, for example, as oxidases, 
monooxygenases, electron transferases, dehydrogenases, disulphide reductases etc. 
(Massey, 2000). There are several examples of oxidative flavoenzymes that transform 
nitroalkanes. These include, 2-nitropropane dioxygenase (2-NPD) from Hansenula 
mrakii (Kido, 1984) or Neurospora crassa (Gorlatova, 1998; Francis et al., 2005), 
nitroalkane dioxygenase from Streptomyces ansochromogenes (Zhang & Tan, 2002), 3-
nitropropionate oxidase (3-NPO) from either Penicillium atrovenetum or Hippocrepis 
comosa (Porter & Bright, 1987; Hipkin et al., 1999), nitroalkane oxidase from Fusarium 
oxysporum (Kido et al., 1978b) (NAO) or glucose oxidase from Aspergillus niger 
(Swoboda & Massey, 1965), and D-amino acid oxidase from mammals (Alston et al., 
1983). Most of the nitrite eliminating enzymes only react with the anionic form of the 
nitro substrate except for 2-NPD from Neurospora crassa, which reacts with the neutral 
and as well as the anionic nitroalkanes (Francis et al., 2005). However, NAO is unique 
since it only catalyzes the neutral nitroalkanes (Gadda et al., 1997). The reactions 
catalyzed with nitro-containing substrates by glucose oxidase and D-amino acid oxidase 
are not physiological, since they do not appear to provide a benefit to the organisms 
(Kido et al., 1978a). In contrast, the reactions catalyzed by each of the other oxidases do 
provide obvious advantages, such as the ability to obtain all nitrogen required for growth 
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from a variety of nitrochemicals or to protect the microbes against host defense 
mechanism. 
 
NAO from Fusarium oxysporum has been very well characterized in the recent 
years (Fitzpatrick et al., 2005). The enzyme is produced in large quantities when cultures 
of the fungus obtain all the nitrogen required for growth from nitroethane (Kido et al., 
1978b). Reasonable physiological roles for the enzyme include: a) that it protects the 
fungus from nitroalkanes produced by plants (Alston et al., 1977), b) to detoxify 
antibiotics produced by the competing soil microbes such as Pseudomonas fluorescens 
(Lee et al., 2003), and/or c) as a strategy to scavenge nitrogen from a variety of 
nitrochemicals. The molecular weight of the 439 residue subunit is 47,955 and analytical 
ultracentrifugation suggests that the enzyme has a quaternary structure comprised of a 
homotetramer/homodimer mixture (Gadda & Fitzpatrick, 1998). The enzyme may be 
located in the peroxisome, since it has amino acid sequence homology in the C-terminal 
region with other enzymes targeted for the peroxisome (Neuberger et al., 2003). 
Furthermore, amino acid sequence comparisons also indicate that NAO is homologous to 
the acyl-CoA dehydrogenase (ACAD) superfamily of flavoproteins, with similarities 
ranging between 7 - 46 % (Fitzpatrick et al., 2005; Ghisla & Thorpe, 2004; Kim & 
Miura, 2004; Daubner et al., 2002). NAO oxidizes a variety of neutral nitro-substrates, 
but does not catalyze acyl-CoA substrates, amino or hydroxy acids (Gadda & Fitzpatrick, 
1998). NAO has a marked preference for unbranched, primary nitroalkanes with four to 
six carbon atoms (Gadda & Fitzpatrick, 1999). For example, the kcat/KM value for NAO 
increases with linear nitroaliphatic substrates with an increasing number of carbon atoms 
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and maximizes with nitrohexane. Indeed, for short primary nitroalkanes, each additional 
CH2 moiety increases the kcat/Km value by 2.5 kcal/mol, and that 1.7 kcal/mol appears to 
be used to increase the binding affinity and the remainder for catalysis (Gadda & 
Fitzpatrick, 1999).  
 
Mechanistic studies of the reaction cycle of NAO, in particular with nitroethane 
as the substrate, have established many of the details of the catalytic cycle (Fitzpatrick et 
al., 2005). The reductive half-reaction is initiated with the abstraction of the substrate 
alpha proton by Asp402 (Figure 1, step 1). Formation of the nitroethane anion is rate-
limiting and 2-2H2-nitroethane exhibits a kcat/Km deuterium isotope effect of 7.5 - 7.9 
(Gadda et al., 2000d; Valley et al., 2005). Thus, a carbanion is definitively established as 
an intermediate in the catalytic cycle (Gadda & Fitzpatrick, 2000e), another unique 
feature of the NAO reaction among flavoenzymes. Moreover, at 25 °C, NAO catalyzes 
the ionization of nitroethane a billion-fold more effectively than does acetate in an 
analogous, non-enzymatic reaction (Valley & Fitzpatrick, 2004). The increase in rate is 
primarily due to a large decrease in the enthalpy of activation, in accord with the concept 
that enzymes generally catalyze reactions by decreasing ΔH‡ as described by Wolfenden 
(Wolfenden et al., 1999). The resulting nitroethyl-anion adds to the flavin N5 to form the 
first covalent intermediate (Figure 1, step 2). The loss of nitrite and subsequent addition 
of hydroxide leads to aldehyde product formation and reduced enzyme (Figure1, steps 3-
5). In the absence of excess nitroethyl anion, the reduced enzyme is rapidly oxidized by 
O2 to yield H2O2 as illustrated by steps 6-7. Alternatively, a stable adduct can be formed 
by addition of a second nitroethane anion to the electrophilic imine intermediate of the 
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original substrate molecule (step 8, ES*). Mass spectrometric analysis of the flavin 
species released from ES* at low pH is consistent with a N5-(2-nitrobutyl)-1,5-dihydro-
FAD adduct (Gadda et al., 1997). The decay of ES* in vitro via step 9 is slow at room 
temperature, pH 8.5, and is O2 independent. However, it does yield oxidized enzyme and 
a similar in vivo reaction is also possible. Consequently, we describe the ES* complex as 
a true reaction cycle intermediate. The remarkable stability of ES* at 4 °C and neutral 





































































































































Figure 1.1 The proposed NAO reaction mechanism with nitroethane as substrate 
(Gadda & Fitzpatrick, 2000e). The imine reaction intermediate after step 3 can 
react with hydroxide to release the aldehyde followed by oxidation by O2 (steps 4-7). 
Alternatively, the intermediate can react with a nitroalkane anion (step 8) to 
generate the ES* complex. It converts to the active enzyme in a pH and/or 
temperature-dependent, but O2 independent manner (step 9) (Nagpal et al., 2005). 
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We solved the structure with Se-Met enriched protein and MAD phasing techniques 
(Hendrickson & Ogata, 1997) using the 52 Se-Met sites of the homotetramer. To our 
knowledge, this is the first crystal structure of a flavoprotein trapped during turnover of 
authentic substrates as a covalent adduct at N5-FAD. We also report the structure of 
oxidized NAO, in which we observe a spermine molecule bound in some of the active 
sites. Together, these structures provide insights into: a) substrate preference and access 
to the FAD, b) the reaction mechanism, and c) the features that differentiate NAO from 

















2 BACKGROUND & SIGNIFICANCE 
 
2.1 Diversity and Utility of Nitrochemicals 
Nitrocompounds are widely used as drugs, herbicides, pesticides and explosives (Figure 
2.1) (Ahlner et al., 1991; Spain, 1995). They are also present in the exhaust of internal 
combustion engines and tobacco smoke. Consequently, they have been distributed 
throughout the environment from man-made sources in vast excess over naturally 
occurring examples. Naturally occurring nitro-compounds include simple compounds 
like nitropropionic acid or more complex examples such as chloramphenicol and 
azomycin. These compounds were first characterized approximately 50 years ago and are 
among the first recognized examples of antibiotics. They also have inspired the 
production of numerous synthetic nitrochemicals. For example, metronidazole is a 
leading drug for the treatment of human ulcers caused by Helicobacter pylori. The 
pathogen contains the rdxA gene, which encodes for an NADPH-dependent, oxygen 
insensitive nitroreductase (Jeong et al., 2000). The enzyme reduces the nitro group of 
metronidazole (-415 mV reduction potential) (Mendz & Megraud, 2002) to yield the 
cytotoxic derivatives that kill the pathogen (Sisson et al., 2000; Sisson et al., 2002; Trinh 
& Reysset, 1998; Samuelson, 1999). Unfortunately, there are increasing numbers of H. 
pylori strains with altered reactivity or expression of the rdxA gene product that are 
metronidazole resistant (Freeman et al., 1997; Goodwin et al., 1998; Mendz & Megraud, 
2002). Explosive compounds such as nitroglycerin (TNG), 2,4,6-trinitrotoluene (TNT), 
RDX and CL-20 do not have any known naturally occurring counterparts; therefore, they 




























































































   
Figure 2.1 Chemical structures and names of some nitrochemicals dispersed throughout the 
environment by natural and man-made sources. 
 11
Nitroglycerin was first synthesized by Sobrero in 1846 and clearly predates the more 
powerful explosives RDX (~1920) and CL-20 (>1975). Many explosives are toxic at 
concentrations well below their solubility limit (Homma-Takeda et al., 2002). For 
example, Prowl ® (Figure 2.1) and related nitroaromatic explosives and pesticides are 
proton transporting ionophores and thus uncouple oxidative phosphorylation. The 
presence of these compounds in the soil and ground water is a major risk factor at some 
EPA superfund sites. Nevertheless, their agricultural and military uses greatly extend 
their distribution throughout the environment with commensurate associated risks to 
human health. 
 
2.2 Biodegradation of Nitrochemicals 
The reductive biotransformation of nitro groups can yield reactive nitroso (R-NO) 
and hydroxylamino (R-NHOH) intermediates (Figure 2.2), which are capable of 
modifying DNA (Nathan & Shiloh, 2000). Reduction of a nitrochemical by six electrons 
is necessary to yield the amino derivative, which can be easily assimilated in proteins and 
nucleic acids. Thus nitrochemicals are often difficult to metabolize, mutagenic or toxic. 
For example, ethylnitrosourea, a potential product of reduction of some nitramines, is a 
strong alkylating agent that causes genetic transversions. Nevertheless, studies of 
microbes isolated from environments containing natural or xenobiotic nitrochemicals 

















































Figure 2.2 The nitrogen cycles. Enzymatic reductions of organic nitrochemicals (left 
portion) yield toxic nitroso- and hydroxylamino- intermediates, but amino 
compounds are assimilated. Denitration reactions yield inorganic nitrite that must 
be transformed into ammonia for assimilation (right portion). Formation of organic 
nitrochemicals occurs through at least two routes: via peroxynitrite (from O2- • and 
•NO) or by direct oxidation of an amino precursor. 
 
 
Nitroesters (R-O-NO2), nitroaromatics (Ar-NO2), nitroalkanes (R-CH2-NO2) and 
nitramines (R2-N-NO2) each serve as sources of nitrogen, carbon and/or energy to some 
microbes (Spain, 1995; Rosser et al., 2001; Spain et al., 2000; Trott et al., 2003; Bhushan 
et al., 2003; Johnson et al., 2002; Williams & Bruce, 2000; Coleman et al., 2002). 
Reductive transformation of R-O-NO2 typically yields an alcohol and eliminates nitrite 
(Spain et al., 2000; Williams & Bruce, 2000, 2002; Williams et al., 2001; Williams et al., 
2004; Binks et al., 1996; Blehert et al., 1997). Interestingly, the explosive compound, 
nitroglycerin is also currently one of the 100 most frequently prescribed drugs for the 
treatment of angina pectoris (Ahlner et al., 1991). Mammalian transformation of 
nitroglycerin by vascular smooth muscle cells is known to yield 1,2-dinitroglycerol, 
nitrite, and eventually nitric oxide (•NO). Chen et al. demonstrated in 2002 that a novel 
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activity of mammalian mitochondrial aldehyde dehydrogenase (mt-ALDH) catalyzes the 
regiospecific, reductive denitration of nitroglycerin to yield nitrite and 1,2-dinitroglycerin 
(Chen et al., 2002). In contrast, reduction of Ar-NO2 tends to yield nitroso and 
hydroxylamino derivatives, but does not liberate nitrite (Spain, 1995; Rosser et al., 2001; 
Johnson et al., 2002; Pak et al., 2000; Spiess et al., 1998; Somerville et al., 1995; French 
et al., 1998). Oxidation of Ar-NO2 by some flavoenzymes eliminates nitrite 
commensurate with hydroxylation (Suzuki et al., 1991; Spain, 1995; Johnson et al., 
2002). Finally, oxidative nitrite elimination from nitroaliphatics occurs with 
incorporation of either solvent or molecular oxygen into the aldehyde or ketone products 
(Dhawale, M. R., and & Hornemann, U., 1979; Gadda et al., 1997; Kido et al., 1976a; 
Kido et al., 1978b). Remarkably, Rhodococcus erythropolis HL PM-1 has very recently 
been shown to encode a complete catabolic pathway for picric acid and several enzymes 
in the pathway use coenzyme F420 (Figure 2.3), a 5-deaza-flavin analog (Heiss et al., 
2003; Rieger et al., 2002; Heiss et al., 2002; Ebert et al., 2001). In addition, CL-20 has 
been recently shown to be transformed by the NADH-dependent, FAD containing 
enzyme, salicylate 1-monooxygenase from Pseudomonas sp. strain ATCC 29352 
(Bhushan et al., 2004). The physiological role of salicylate 1-monooxygenase is to 
biotransform salicylate to catechol but the enzyme also transforms CL-20, o-nitrophenol 
and benzoates at a lower reaction rate (Suzuki et al., 1991). Therefore, although natural 
sources of nitrochemicals may appear scarce and nitrochemicals introduced by human 
activities are often considered toxic, they can be efficiently exploited by microbial 
communities. They may even be rapidly turned over by a heretofore uncharacterized 
“metabolic economy”. The assimilation of priority pollutants found in some of EPA 
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superfund sites is eagerly anticipated. However, the catabolism of drugs by human 
pathogens is also occurring, which is not as desirable a scenario.  
 
Organic nitrocompounds can be produced from precursor amines by two 
biological pathways, collectively called nitration. In the first pathway, the amino 
precursor of chloramphenicol, for example, is oxidized directly to the final nitro-
containing antibiotic by an oxidase with an uncharacterized reaction mechanism (van 
Pee, 1996). The second pathway is responsible for the production of nitro-substituted 
amino acids such as 3-NO2-tyrosine. This represents a potentially ubiquitous class of 
naturally occurring nitrochemicals (Nathan & Shiloh, 2000; MacMicking et al., 1997; 
Bogdan, 2001). It is now recognized that 3-NO2-Tyr and other nitrated protein residues 
are important post-translational markers for oxidative damage, septic shock, Alzheimer’s 
disease as well as many cardiovascular, neurodegenerative and malignant conditions 
(Aulak et al., 2004; Aulak et al., 2001; Irie et al., 2003; Kamisaki et al., 1998; Schopfer 
et al., 2003; Turko et al., 2003). For example, mammalian phagocytes actively engaged 
in combating a microbial infection produce nitric oxide (generated by inducible nitric 
oxide synthase) and superoxide (O2- •, generated by NADPH phagocyte oxidase) (Nathan 
& Shiloh, 2000; Xu & Liu, 1998). Nitric oxide is normally derived from arginine by 
nitric oxide synthase and has many physiological functions, including vasodilatation 
(Nathan & Shiloh, 2000; Bogdan, 2001; MacMicking et al., 1997; Xu & Liu, 1998). The 
•NO and O2 -• react to produce peroxynitrite (OONO -), which is proposed to generate 3-
NO2-Tyr and other nitrated amino acids in proteins (Aulak et al., 2004; Aulak et al., 
2001; Turko et al., 2003; Miyagi et al., 2002). Nitrated proteins, amino acids and 
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metabolites may possess antibiotic activity and consequently mitigate bacterial and/or 
fungal infection (Turko & Murad, 2002; Kamisaki et al., 1998). Recent proteomic studies 
suggest that the presence of 3-NO2-Tyr in proteins is dynamically linked to the 
physiological status of the cell, tissue and organ (Aulak et al., 2004; Turko et al., 2003; 
Shishehbor & Hazen, 2004; Kuhn et al., 2004; Gow et al., 2004; Butterfield, 2004; Aulak 
et al., 2004). More than 40 proteins are rapidly nitrated and denitrated as conditions 
change (Koeck et al., 2004; Duncan, 2003; Ye et al., 1996; van der Vliet et al., 1996; 
Crow & Ischiropoulos, 1996; Aulak et al., 2004). They are found in the cytosol and the 
mitochondria and the level of nitration is dependent upon the physiological status of the 
cell or tissue type. However, very little is known about the nitration and denitration 
mechanisms, the processes are likely to be analogous to the ubiquitous phosphorylation 
cycles of Ser, Thr and Tyr residues and metabolites in most life forms.  
 
2.3 Flavoproteins are Ubiquitous in Biochemistry 
As suggested above, many of the biological transformations of organic nitrochemicals 
are either catalyzed by, or otherwise involve flavoproteins. FAD and FMN are the most 
common organic cofactors found in enzymes (Massey, 2000; Fraaije & Mattevi, 2000; 
Ghisla & Massey, 1989). Consequently, they facilitate very diverse catalytic activities 
(Palfey & Massey, 1998). The isoalloxazine ring system in flavoenzymes is ideally suited 
for oxidative or reductive reactions involving one or two electron processes, as well as 
reactivity with molecular oxygen (Figure 2.3). Thus flavoproteins couple two-electron 
metabolic processes to one-electron transfer processes of respiration.  
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Figure 2.3 A structure-based hypothesis for reactivity in flavoenzymes. Depending 
upon the redox state, the isoalloxazine ring either shows a planar or bent 
conformation. The reaction of the reduced flavin with O2 is likely to proceed via 
C4a-hydroperoxide intermediate formation (Bruice, 1980). 
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They are also involved in bioluminescence, programmed cell death, detoxification, 
DNA repair and photosynthetic processes. Moreover, the isoalloxazine ring facilitates 
catalysis in many types of enzymes because it can act as an electrophile, a nucleophile or 
form a covalent intermediate at either N5 or C4a. Not surprisingly then, FAD and FMN 
are among the most common organic cofactors found in biochemistry.  
 
A myriad of fundamentally similar interactions influence each reaction coordinate 
and yet, yield remarkable catalytic diversity. Moreover, selective pressure and evolution 
have enhanced “desirable” reaction(s), while simultaneously decreasing deleterious 
reaction(s). Although more than 550 flavoprotein structures have been deposited in the 
PDB, much debate remains as to how an active site environment influences a given 
reaction coordinate. However, far less is known about how different reactions can occur 
with similar substrates and flavin cofactors. The study of the different enzymes that 
transform nitrochemicals, but employ different reaction mechanisms, will provide 
insights into these reaction processes.  
 
The reaction(s) of a particular flavoprotein derive from a complex combination of 
interactions. These include the flavin cofactor itself, protein active site residues, substrate 
molecule(s) and inclusion or exclusion of solvent molecules and/or ions. A few well-
studied flavoenzymes support proposals for several of these features. For example, 
structural analysis of numerous dehydrogenases, oxidases and reductases reveal that 
substrates often bind parallel to the isoalloxazine ring, but often on opposite faces (Figure 
2.3) (Fraaije & Mattevi, 2000). The dehydrogenases and oxidases frequently bind 
 18
substrates adjacent to the re-face, whereas reductases often bind substrates parallel to the 
si-face. In contrast, p-hydroxybenzoate 3-hydroxylase and many other oxygenases, bind 
substrates near the top edge of the reduced flavin (Palfey et al., 1999; Schreuder et al., 
1994; Gatti et al., 1994; Schreuder et al., 1992; Schreuder et al., 1989; Schreuder et al., 
1988; Wierenga et al., 1979). Thus the three-dimensional binding relationship between 
the substrate(s) and the cofactor profoundly influences the reaction. The reduction 
potential of the flavin is thought to be influenced by the presence of either positive or 
negative charge near the redox active N5 - N1 pair. For example, a positive charge near 
N1 appears to increase the reduction potential and may also stabilize the anionic state at 
N1 in the reduced cofactor (Ortiz-Maldonado et al., 2004; Moran et al., 1997; Wu et al., 
2003; Stankovich et al., 1999; Johnson & Stankovich, 1993; Byron et al., 1990; Fink et 
al., 1986; Stankovich & Fox, 1984). Hydrogen bonding to N5 is thought to polarize the 
Lowest Unoccupied Molecular Orbital (LUMO) and (Highest Occupied Molecular 
Orbital (HOMO) of the N5 atom of oxidized flavins. Indeed, theoretical studies suggest 
that a hydrogen bond donor approximately in the plane of the isoalloxazine ring will 
orient the LUMO approximately perpendicular to the plane (Ghisla & Thorpe, 2004; 
Bach & Dmitrenko, 2004; Satoh et al., 2003; Dmitrenko et al., 2003; Bach et al., 2002; 
Bach & Dmitrenko, 2003). Consequently, the electrophilicity at this position is increased 
and hydride transfer is enhanced, provided that substrates are also suitably oriented and 
parallel to the plane of the isoalloxazine ring. Third, several gas-phase theoretical studies 
and crystallographic studies of free flavins and flavin analogs have shown that the two 
electron reduced isoalloxazine ring is “bent” by up to 30° along the N5-N10 axis (Guo et 
al., 2002; Rizzo, 2001; Reibenspies et al., 2000). Such a “butterfly” conformational 
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change associated with redox perturbation should significantly influence catalysis in 
flavoproteins. Moreover, reaction with O2 at C4a, or other acceptor molecules at either 
N5 or C4a, can then occur from either the re-face or the si-face. However, there are 
structurally defined examples where oxidized flavoenzymes have significantly bent 
isoalloxazine rings (Satoh et al., 2003; Binda et al., 2003; Binda et al., 2002a; Binda et 
al., 2002b) and other examples where reduced flavoproteins contain almost planar 
cofactors (Gatti et al., 1994; Schreuder et al., 1992; Bach & Dmitrenko, 2004; Khan et 
al., 2004; Ortiz-Maldonado et al., 2003; Khan et al., 2002; Barna et al., 2001; Ortiz-
Maldonado et al., 1999). The protein environment is thought to play a significant role in 
stabilizing these “higher energy” states. Thus, comprehensive rules that yield a given 
reaction coordinate remain to be defined in most flavoproteins.  
 
2.4 Identification of Nitroalkane Oxidase as a Flavoprotein 
**The ability of organisms to oxidize nitroalkanes to the respective aldehyde or 
ketone plus nitrite has been known for several decades (Little, 1951). The activity is 
found in both bacteria and eukaryotes; the latter are predominantly yeast and fungi (Kido 
et al., 1975), although there is a report of a plant 3-nitropropionate oxidase (Hipkin et al., 
1999). Most of these enzymes are more active on secondary nitroalkanes than on primary 
nitroalkanes (Kido et al., 1975). Several such enzymes have been purified (Kido et al., 
1976b; Gorlatova et al., 1998; Dhawale, M. R., and & Hornemann, U., 1979; Kido et al., 
1978a); in each case, nitropropane is the best substrate and the stoichiometry of the 
                                                 
** The sections on NAO in this chapter are reformatted from the review article published by (Fitzpatrick et 
al., 2005) 
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reaction is as shown in Scheme 2.1, so that these enzymes are classified as 2-nitropropane 
dioxygenases. The enzymes from Hansenula mrakii and Neurospora crassa are both 
flavoproteins (Kido et al., 1976b; Gorlatova et al., 1998; Francis et al., 2005) and 




2 +  O2 H3C C CH3
O
2 +  2HNO2
 
Scheme 2.1 
Nitroalkanes are unusual acids, in that the anion protonates very slowly even at 
neutral pH and the nitro moiety lowers the pKa value of the α-carbon to below 11 (Lewis, 
1982), so that the anion can be used as a substrate at neutral pH. As a result, it has been 
possible to show that nitroalkane dioxygenase from Neurospora crassa is more specific 
for nitronates of 2-nitropropane and primary nitroalkanes with alkyl chain lengths 
between 2 and 6 carbons rather than the neutral substrates. With neutral nitroalkanes and 
anionic nitronates other than propyl-1- and propyl-2-nitronate, for which a non-enzymatic 
free radical reaction involving superoxide was established using superoxide dismutase, 
substrate oxidation occurs within the enzyme active site (Francis et al., 2005). 
 
In 1978, Kido et al., described an enzyme from Fusarium oxysporum which 
oxidized a number of primary and secondary nitroalkanes (Kido et al., 1978b). In contrast 
to the 2-nitropropane dioxygenases, this enzyme was more active on primary 
nitroalkanes. In addition, the reaction stoichiometry (Scheme 2.2) indicated that the 
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enzyme is properly termed a nitroalkane oxidase (NAO). NAO was present at much 
higher levels when the cells were grown in the presence of nitroethane, suggesting that 
nitroethane is a physiological substrate (Kido et al., 1978b). While the enzyme was 
reported to have an absolute requirement for FAD for activity (Kurihara et al., 1994), 
suggesting that it was a flavoprotein, the visible absorbance spectrum showed no 
evidence of the typical flavin absorbance (Figure 2.4). However, if the protein was 
denatured at neutral pH, a stoichiometric amount of FAD was released (Kurihara et al., 








Figure 2.4 UV-Visible spectra of NAO as isolated from Fusarium oxysporum in contrast to 
spectra of oxidized FAD (Gadda et al., 1997) 
+  O2  +  H2O +  H2O2  + R CH2 NO2 R C H
O
NO2- + H+ 
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The structure of the cofactor in NAO as isolated from the fungus was determined 
by mass spectrometry, taking advantage of the stability of the protein-free cofactor at low 
pH. This showed two species with m/z- values of 784.1415 ± 0.0068 and 887.2138 ± 
0.0078. The smaller was identified as FAD, which has a molecular weight of 784; this 
was presumably formed during the laser desorption ionization process. The difference of 
103.0645 ± 0.0103 between the two species established the cofactor as FAD plus 
C4H9O2N; the added mass is equivalent to two nitroethane molecules minus nitrite. 
Consequently, the structure in Scheme 2.3 was proposed for the cofactor. When NAO 
containing this modified FAD was incubated at 37 oC, there was a slow conversion to an 
enzyme with a more typical flavoprotein spectrum. The activity of the enzyme showed a 
simultaneous large increase in activity, establishing that the cofactor adduct is not the 
active form of the cofactor (Gadda et al., 1997). The FAD in the active enzyme could be 
removed reversibly and quantitatively to yield apoenzyme devoid of activity. This could 
be reconstituted with 5-deaza-FAD; the enzyme containing the modified flavin has no 
catalytic activity, and nitroethane does not reduce the flavin (Gadda & Fitzpatrick, 1998). 
These results established that active NAO contains unmodified FAD as the cofactor and 
suggested that the adduct is formed in the fungal cell during incubation with nitroethane. 
 
2.5 Mechanistic Studies on Nitroalkane Oxidase 
Consistent with a redox role for the flavin cofactor in NAO, addition of neutral 
nitroethane to the FAD-containing form of the enzyme under anaerobic conditions results 
in an enzyme with a visible absorbance spectrum typical of reduced flavin; upon removal 
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of the substrate by aerobic gel filtration, the spectrum returns to that of oxidized flavin, 
with no evidence for any flavin N5-adduct. In contrast, if the enzyme is incubated with a 
mixture of neutral and anionic nitroethane, the resulting flavin is in the form of the adduct 
(Gadda et al., 1997). This result is consistent with the mechanism of Scheme 2.4 for the 
formation of the adduct and with the neutral nitroalkane being the normal substrate. 
Formation of such an adduct would require one molecule of neutral nitroethane and one 
of the anion. Since the pKa of nitroethane is 8.5, addition of nitroethane to cells at pH 8.0 
would result in a mixture of the two forms in the growth media. Precedent for the 
mechanism of Scheme 2.4 comes from the reaction of D-amino acid oxidase with 
nitroethane anion; in that case a flavin adduct was trapped in the presence of cyanide and 












































































Thus, NAO differs from the 2-nitropropane dioxygenases in that catalysis 
involves the neutral nitroalkane. This preference of NAO for the neutral nitroalkane as 
substrate was confirmed by examining the kcat/Km pH profile for nitroalkane oxidase with 
a series of nitroalkanes with different pKa values; if the substrate is allowed to reach an 
equilibrium protonation state at each pH before beginning the assay, the pKa for basic 
limb of the bell-shaped pH profile matches that of the substrate (Heasley & Fitzpatrick, 
1996). Since the initial steps in the formation of the flavin adduct involve the neutral 
nitroalkane, it is a reasonable assumption that these steps are along the normal catalytic 
pathway. Scheme 2.5 provides a mechanism consistent with these observations. Both 
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catalysis and inactivation begin in the same fashion, with proton abstraction from the 
neutral nitroalkane by an active site base. Nucleophilic attack of the nitroalkane anion on 
the flavin followed by nitrite loss would form an electrophilic cation. Attack by 
hydroxide rather than a nitroalkane anion on the cation would form a species which could 
eliminate the respective aldehyde to form reduced FAD. This provides a reasonable 











































































































Scheme 2.5 (Nagpal et al., 2005) 
 
The kinetic mechanism of NAO with nitroethane and 1-nitrobutane as substrates 
has been examined using single turnover methods (Valley & Fitzpatrick, 2003a). The 
results are consistent with the mechanism of Scheme 2.6, where P1 and P2 are the 
products nitrite and acetaldehyde. This mechanism is similar to that seen with most 
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flavoprotein oxidases, in that flavin reduction occurs prior to the reaction with oxygen 
(Palmer & Massey, 1968; Bright & Porter, 1975) With nitroethane as substrate, cleavage 
of the substrate CH bond is rate-limiting for reduction, based on comparison of the 
isotope effects with [1,1-2H2]nitroethane on the kcat/Km value for nitroethane and on the 
limiting rate of reduction of the flavin measured in the stopped-flow spectrophotometer. 
The isotope effect on kcat is much smaller, establishing that product release or a 
conformational change limits kcat. 
 
k1 k3 k4
EFADox + S EFADoxS EFADredP1P2
k2 EFADoxP1P2 EFADox + P1 + P2
k-1 O2 H2O2  
Scheme 2.6 
 
The best substrates for NAO are linear primary nitroalkanes (Gadda & 
Fitzpatrick, 1999). Introduction of a hydroxyl group decreases the kcat/Km value about 
200-fold. Comparison of the effect of chain length on the kcat/Km value showed a 
monotonic increase with each additional methylene group from nitroethane to 1-
nitrobutane increasing the kcat/Km value by 20-fold and no further increases with 1-
nitropentane or 1-nitrohexane. This is consistent with a contribution of 2.6 kcal/mol for 
each additional methylene, suggesting that the active site of NAO is a hydrophobic 
channel. A similar contribution of each methylene group has been found for stearoyl acyl 
carrier protein Δ9-desaturase (Haas & Fox, 1999). 
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The kcat/Km pH profile with nitroethane as substrate shows that an enzyme base 
with a pKa value of 7.0 must be unprotonated for catalysis (Gadda & Fitzpatrick, 2000e). 
This is presumably the active site base in Schemes 2.4 and 2.5, a conclusion subsequently 
confirmed by site-directed mutagenesis (vide infra). An identical pKa is seen in the Ki pH 
profile for the competitive inhibitor valerate; this result and the isotope effect on the 
kcat/Km value for nitroethane establish 7.0 as the intrinsic pKa value of the base. With 
primary nitroalkanes of increasing chain length, the pKa seen in the kcat/Km pH profile 
shifts to lower values and the deuterium isotope effect on the kcat/Km value decreases. For 
the kinetic mechanism of Scheme 2.6, both effects can be attributed to an increase in the 
forward commitment to catalysis, k2/k-1. This has allowed the effects of chain length on 
the Kd value, k-1/k1, and on catalysis, k2, to be separated. As the chain length increases 
from nitromethane to 1-nitrobutane, each methylene group results in a decrease of the Kd 
value of 15-fold, equal to 1.7 kcal/mol, and an increase in k2 of 4-fold . With nitroethane 
as substrate, the value of k2 has been directly measured as 250 s-1 by stopped-flow 
methods, while that for 1-nitrobutane is at least 4000 s-1 (Valley & Fitzpatrick, 2003b). 
 
 As noted above, with nitroethane as substrate the rate-limiting step for flavin 
reduction is formation of the nitroethane anion. Accordingly, the acetate-catalyzed 
formation of nitroethane anion provides a nonenzymatic model for the reaction of NAO. 
The temperature dependences of both the enzymatic and the acetate catalyzed reactions 
were determined as a function of temperature for nitroethane and [1,1-2H2]nitroethane 
(Valley & Fitzpatrick, 2004). In the case of the enzyme, the temperature dependence of 
the kcat/Km value for nitroethane was determined, since this provides the appropriate 
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second order rate constant for comparison with the second order rate constant for the 
nonenzymatic reaction. Direct comparison of the rate constants for the enzymatic and 
nonenzymatic reactions gives a value for the rate acceleration by NAO of 1.2 billion-fold. 
This is likely to be an underestimation of the catalytic power of the enzyme, since the 
kcat/Km value for 1-nitrobutane is 400-fold that for nitroethane and is limited by binding 
rather than anion formation (Gadda & Fitzpatrick, 1999; Gadda et al., 2000d), while the 
second order rate constant for nonenzymatic ionization of 1-nitrobutane is comparable to 
that for nitroethane (Gadda et al., 2000d).  
 
Analyses of the temperature dependence of the enzymatic and non-enzymatic 
reactions allowed calculation of the thermodynamic parameters for formation of the 
transition state in each case. The rate increase seen in the enzyme-catalyzed reaction 
could be attributed to a decrease in ΔH‡ of 18.6 kcal/mol (Valley & Fitzpatrick, 2004), in 
agreement with the observation of Wolfenden that enzyme reactions typically exhibit 
large decreases in ΔH‡ compared to the corresponding nonenzymatic reactions 
(Wolfenden et al., 1999). More uniquely, analysis of the temperature dependence of the 
deuterium isotope effects on the rate constants could be used to probe the contribution of 
quantum mechanical tunneling to the reaction and to determine if there was a greater 
contribution of tunneling to the enzyme catalyzed reaction. Deuterium or tritium isotope 
effects greater than the semiclassical value, 7 or 16, respectively, are often taken as an 
indication of a contribution from tunneling. However, deuterium isotope effects 
significantly less than 7 can occur in reactions involving quantum mechanical behavior 
(Kohen & Klinman, 1999). A more reliable criterion for a contribution of tunneling to a 
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reaction is the isotope effect on the Arrhenius prefactor A. This is expected to have a 
value of unity in the absence of tunneling, although more realistic limits are 0.6-1.4 (Bell, 
1974). Tunneling can result in isotope effects on A above or below this range, depending 
upon the magnitude of the contribution from tunneling to the reaction (Kohen & 
Klinman, 1999). In the case of NAO, the value of AH/AD is within the range expected in 
the absence of a significant tunneling contribution, 0.85 ± 0.35 (Valley & Fitzpatrick, 
2004). More importantly, it is comparable to that for the nonenzymatic reaction, 0.89 ± 
0.25. While this is consistent with a lack of contribution of tunneling to both reactions, it 
is more correct to conclude that tunneling contributes to an equivalent extent to the 
enzymatic and nonenzymatic reaction.  
 
Because CH bond cleavage is rate-limiting with nitroethane, the best 
characterized substrate for NAO, the understanding of this step is better understood than 
the subsequent steps in catalysis. A critical question is whether the flavin adduct formed 
by attack of the nitroalkane anion during inactivation is also on the normal catalytic 
pathway, as proposed in Scheme 2.5. Cyanide has been used to trap this intermediate and 
establish its kinetic competency (Valley et al., 2005). When assays are carried out with 
nitroethane in the presence of cyanide the enzyme rapidly loses activity. Rapid reaction 
analyses establish that cyanide can react with the enzyme in the presence of nitroethane at 
the same rate as nitroethane can reduce the flavin and that inactivation occurs before 
reaction of the reduced enzyme with oxygen. Use of 1,1-[2H2]nitroethane decreases the 
rate of inactivation by cyanide; the isotope effect equals the isotope effect on the kcat/Km 
value. These results are consistent with cyanide intercepting a species which is formed 
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during normal turnover after removal of the substrate proton but before formation of fully 
reduced flavin and aldehyde. Mass spectrometry of the flavin isolated from the cyanide-
inactivated enzyme establishes that it is in the form of an N5-flavin adduct analogous to 
that of Scheme 2.3, but with a cyano moiety replacing the second nitroethyl group; i. e., 
5-cyanoethyl-1,5-dihydro-FAD. This is consistent with cyanide inactivation involving a 
mechanism similar to that of Scheme 2.4, and establishes the intermediacy of the 
electrophilic flavin cation in Schemes 2.4 and 2.5 in normal catalysis. 
 
A direct nucleophilic attack of the anion on the flavin is the most straightforward 
mechanism for formation of this adduct. However, in studies of the reactions of anions 
with flavins, the formation of N5 adducts is suggested to involve a radical intermediate 
(Scheme 2.7) (Bruice, 1980). While the mechanism of nitroethane anion addition to 
oxidized FAD has not been examined for NAO, it has been in the case of D-amino acid 
oxidase (DAAO). DAAO will not react with neutral nitroethane, but will catalyze the 
oxidation of nitroethane anion to acetaldehyde and nitrite (Porter et al., 1973). Although a 
5-nitrobutyl adduct is apparently not formed, if this reaction occurs in the presence of 
cyanide, a 5-cyanoethyl FAD adduct analogous to that in NAO and Scheme 2.3 can be 
isolated. While the DAAO reaction is certainly not physiological, it does serve as a model 
for the NAO reaction. When [1-2H]nitroethane anion is used in the DAAO reaction, there 
is an isotope effect of 0.84 on the kcat/Km value (Kurtz & Fitzpatrick, 1997). This is 
consistent with a change in hybridization at the α-carbon from sp2 to sp3. In solution the 
nitroethane anion is the nitronate, so that the α-carbon is sp2 hybridized (Bordwell & 
Boyle Jr., 1975). This carbon would similarly be sp2 hybridized in the nitronate radical, 
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but sp3 in the adduct. The inverse isotope effect in the DAAO reaction is most consistent 
with the radical not being an intermediate in formation of the adduct, but rather a 
mechanism involving direct nucleophilic attack of the nitronate on the flavin. By analogy, 
the NAO reaction would similarly involve a direct nucleophilic attack on the cofactor by 







































2.6 Nitroalkane Oxidase, a New Member of Acyl-CoA Dehydrogenase 
Family 
Using the sequences of tryptic peptides to generate oligonucleotide probes, the 
cDNA for nitroalkane oxidase was isolated from a F. oxysporum cDNA library of cells 
expressing the enzyme. The protein sequence derived from the cloned cDNA showed that 
the enzyme had homology to members of the acyl-CoA dehydrogenase (ACAD) family 
(Daubner et al., 2002) . The identity extends throughout the entire sequence, and the 
regions of greatest divergence correspond to external loops in the structure of medium 
chain ACAD (MCAD). While this homology was unexpected, it does make chemical 
sense. Both enzymes are flavoproteins which catalyze the abstraction of an acidic proton 
as the first step in catalysis (Scheme 2.5, Figure 2.5), after which the mechanisms 
diverge. In the case of the MCAD, the base is Glu376 (Thorpe & Kim, 1995) but same 
role is played by Asp402 in NAO. Mutagenesis of Asp402 in NAO to glutamate 
decreases the rate of CH bond cleavage by the enzyme by 15 to 20-fold, while 
mutagenesis to asparagine or alanine decreases the rate at least 100-fold (Valley & 
Fitzpatrick, 2003a, 2003b). In addition, the kcat/Km pH profiles for the D402N and D402A 
enzyme no longer show a pKa of 7 (Valley & Fitzpatrick, 2003a). This is consistent with 
Asp402 being the active site base with a pKa of 7. The long lifetimes of nitroalkane 
anions in solution at neutral pH made it possible to more directly determine whether 
Asp402 was indeed the base responsible for abstracting a proton from the substrate to 
form the anion. At pH 8, the D402A enzyme has no significant activity above 
background with neutral nitroethane as substrate. However, use of nitroethane anion as 
the substrate results in recovery of substantial activity (Valley & Fitzpatrick, 2003a). This 
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rescue of the mutant with the anion provides strong support for the proposed role of 
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Mechanistic studies of the ACAD enzymes were pioneered by Helmut Beinert 
almost five decades ago (Steyn-Parve & Beinert, 1958b, 1958a; Beinert & Page, 1957; 
Crane et al., 1956a; Hauge et al., 1956; Crane & Beinert, 1956b) and the research area is 
still very active. Indeed, the structural, mechanistic, mutagenic and spectroscopic analysis 
of the MCAD provides exquisitely detailed proposals for the structural contributions to 
catalysis (Kim & Miura, 2004; Ghisla & Thorpe, 2004). However, to our knowledge 
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none of the ACAD or ACO enzymes will transform nitroalkanes, nor will NAO 
transform acyl-CoA substrates (Daubner et al., 2002). Members of the ACAD 
superfamily are roughly classified into four branches based upon substrate preference and 
reaction type (Ghisla & Thorpe, 2004; Kim & Miura, 2004; Tanaka & Indo, 1992). The 
first branch catalyzes the catabolism of fatty acids via β-oxidation. The chain length of 
the acyl-thioester substrate dictates which ACAD homolog catalyzes the α, β-
dehydrogenation reaction to yield the corresponding trans-2,3-enoyl CoA product. Thus 
the short, medium, long and very long chain acyl-CoA dehydrogenases demonstrate 
preferences for C4-C8 (SCAD), C4-C16 (MCAD), C10-C16 (LCAD) and >C16 (VLCAD), 
respectively. Because of the many prolific research groups focused on the MCADs, they 
are the best characterized of the whole superfamily (Ghisla & Thorpe, 2004). The second 
group of homologs is specific for branched acyl-thioester substrates encountered in 
amino acid catabolism. In mammals, the enzymes from the first two branches are located 
inside the mitochondrial matrix and transfer two reducing equivalents to the electron-
transferring flavoprotein (ETF) (Crane et al., 1956a). The reducing equivalents are 
subsequently passed on to the ETF-dehydrogenase and then to the respiratory chain for 
ATP production. Thus, these members of the ACAD superfamily evolved a strategy to 
prevent oxidation of FADH- by O2 as discussed in two recent reviews (Ghisla & Thorpe, 
2004; Kim & Miura, 2004). The third branch is a more distantly related group of 
peroxisomal enzymes which degrade longer fatty acid chains (>C23). These enzymes 
transfer the reducing equivalents to oxygen to produce H2O2 and are thus acyl-CoA 
oxidases (ACO) (Setoyama et al., 1995; Kunau et al., 1995; Osumi et al., 1980; Inestrosa 
et al., 1979), (Pedersen & Henriksen, 2005). The fourth group of enzymes has only 
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recently emerged and is best characterized for the acyl-carried protein dehydrogenase 
(ACPD) from Streptomyces hygroscopicus. They function in the biosyntheses of the 
immunosuppressive and antifungal macrolides FK520 and FK506 (Wu et al., 2000; 
Motamedi & Shafiee, 1998). These ACAD homologs are essential for the synthesis of the 
unique “glycolate” extender units that are incorporated into many polyketide backbones 
by modular polyketide synthetases (Carroll et al., 2002; Cane et al., 1998; Walsh, 2004). 
It seems unlikely that an ETF analog is essential in this enzyme system.  
 
At least one crystal structure is available from each branch (Nagpal et al., 2004; 
Kim & Miura, 2004; Battaile et al., 2004; Watanabe et al., 2003; Satoh et al., 2003; 
Nakajima et al., 2002; Lee et al., 1996; Thorpe & Kim, 1995; Djordjevic et al., 1995; 
Kim, J. J. et al., 1993; Kim et al., 1992; Kim & Wu, 1988; Battaile et al., 2002; Pedersen 
& Henriksen, 2005). With amino acid sequence similarity to NAO as low as 7-9% for 
ACO and ACPD, respectively; potential homologs cannot be unambiguously identified 
from sequence alignment alone. Indeed, BLAST searches with NAO do not return ACO 
as a homolog.  
 
The oxidative half-reactions of NAO and ACO differ from that of MCAD (Ghisla & 
Thorpe, 2004). In particular, reduced MCAD with trans-2,3-enoyl CoA bound does not 
react with O2. Because the enoyl-CoA product binds to the reduced MCAD with more 
affinity, it does not dissociate readily. The tight product binding in case of ACADs 
prevents the O2 access to the FADH- species, principally by steric exclusion. However, 
the reduced MCAD-(enoyl-CoA)-FADH- complex binds to the ETF protein. The 
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complex is hypothesized to transfer reducing equivalents in two one-electron transfer 
events, since the inter flavin distance in the complex does not permit direct contact 
between redox partners (Parker, 2003; Roberts et al., 1996; Roberts et al., 1999). A very 
recent crystal structure of the complex between MCAD-ETF supports this theory and 
furthermore suggests significant conformational flexibility is an essential feature of the 
complex (Toogood et al., 2004). The affinity of oxidized MCAD for the enoyl-CoA 
product is greatly reduced, allowing it to dissociate. In contrast, NAO and ACO transfer 
their reducing equivalents to O2 and produce H2O2. The sequence alignments suggest that 
Ser171 in NAO is analogous to Gly178 in ACO-II and to Gly177 in ACO-I, which may 
increase the accessibility of O2 to FADH- species. Thus ACO may allow enoyl-CoA 
products to dissociate readily and/or allow oxygen access even in the product complex. 
However, the active site of NAO is much more similar to MCAD than ACO. The detailed 
crystal structure analysis of NAO and its reaction intermediates will help in 
understanding the structural basis for the different activities, as well as potential ancestral 










3 MATERIALS & METHODS 
 
This chapter details the experimental techniques used to solve the crystal structures of 
a substrate trapped N5-FAD adduct of NAO (ES*) and the oxidized form of NAO to 2.2 
Å and 2.07 Å resolutions, respectively. X-ray structure determination of NAO in its 
different reaction states was not only of interest from a catalytic viewpoint, but also from 
a crystallographic viewpoint, owing to the challenges encountered during this project. To 
list a few of the challenges, numerous soaking and co-crystallization trials with a wide 
variety of heavy atoms to phase ES* were unsuccessful. The attempts of solving the 
structure with molecular replacement were also futile. After much struggle, the structure 
of ES* was finally solved with the SeMet MAD phases derived from the location and the 
refinement of 52 selenium sites.  The large number of selenium sites in ES* gave us a 
chance to learn a great deal about different phasing programs, their capacities, and their 
limitations. To our knowledge, this is one of the few SeMet structures with such a large 
number of selenium sites. 
 
Although the crystal structure of EI was solved by using ES* as a molecular 
replacement search model, the collection of native data in this case, pushed the limits of 
synchrotron facilities at Brookhaven and Argonne National Labs. The EI crystals grew 
with an exceptionally long c axis (485 Å) and a huge unit cell volume (4,570,000 Å3). 
The crystal form was interesting and worth pursuing since it diffracted to a very high 
resolution (1.6 Å) and had a very low mosaic spread (0.3°). After 2 years of struggle and 
innumerable synchrotron trips, we were able to collect and process 2.07 Å resolution 
native data of EI. Out of total 31,644 protein structures deposited in PDB, only 17 crystal 
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structures have a c axis greater than 485 Å. None of the protein crystal structures with a c 
axis greater than 485 Å diffract to a resolution greater than 2.2 Å, which makes the 
crystal structure of EI, the highest resolution structure deposited in PDB.  
 
3.1 X-ray Structure Determination of N5-(2-nitrobutyl)-1,5-dihydro-
FAD Adduct of NAO (ES*) 
 
3.1.1 Protein Expression and Purification of ES* and SeMet-ES* 
Recombinant nitroalkane oxidase was expressed and purified from E.coli strain BL21 
(DE3) transformed with pETNAO4  (Daubner et al., 2002; Valley & Fitzpatrick, 
2003b).The purified enzyme was stored in 20 mM HEPES pH 8.0,1 mM EDTA, 5% 
glycerol and aliquots were flash frozen with liquid N2. SeMet-ES* was obtained by 
expression in the methionine auxotroph E.coli B834 (DE3) (Novagen) as previously 
described (Nagpal et al., 2004). To generate the covalent adduct, 25 µM NAO was 
incubated with 28 mM neutral nitroethane and 9 mM anionic nitroethane in 500 mM 
HEPES, pH 8.0, for 1 hour at 25 °C. The enzyme was then exchanged into 20 mM 
HEPES, pH 8.0, 1 mM EDTA, 5% glycerol at 4 °C using an Ultrafree-15 centrifugal 
filter device (Millipore Co., Bedford, MA) and aliquots were flash frozen with liquid N2. 
NAO has a subunit molecular weight 47,955 Da, each of which contains 13 methionine 




3.1.2 Crystallization of ES* and SeMet-ES* 
Microcrystalline showers of the ES* were initially obtained from the flexible sparse 
matrix screen prepared according to (Zeelen et al., 1994). Diffraction quality crystals 
were obtained at 4 °C by mixing 2 µl of 10 mg/ml protein solution (in 10 mM PIPES, pH 
7.5) with 2 µl of reservoir solution containing 20% w/v PEG 1500, 300 mM ammonium 
sulphate in 150 mM PIPES (pH 7.5) (Figure 3.1 a). The crystals typically grew within 20 
days with the hanging drop, vapor diffusion method. Single crystals of SeMet-ES* were 
grown from similar conditions except for the addition of 10 mM tris(2-carboxyethyl) 
phosphine hydrochloride (TCEP-HCl) to the crystallization drop. Crystals in natural and 
SeMet enriched forms of ES* grew in orthorhombic space group with similar cell edges 
(a = 90.5 Å; b = 163.9 Å; c = 172.3 Å).  
 
3.1.3  X-ray Data Collection and Processing of Native ES* 
Single crystals were mounted in nylon loops (no cryoprotectant was necessary) and 
flash frozen by quick submersion into liquid N2. All X-ray diffraction data were collected 
from crystals held at approximately 100 K. The native dataset for ES* was collected with 
180° phi rotation at beamline X26C of the NSLS using 1.0 Å x-rays and an ADSC 
Quantum 4 detector. Each image was collected with 60 sec exposure, 0.5° oscillation and 
200 mm crystal to detector distance (Figure 3.1 b, c). The crystals diffracted to 2.3 Å 
resolution with 99.9 % completion in the highest resolution shell.  
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Figure 3.1 a) Crystals of the N5-FAD adduct of nitroalkane oxidase photographed 
without polarization (0.3 X 0.09 mm), b) The x-ray diffraction pattern at 100K with 
rotation about the vertical axis collected with ADSC Quantum 4 detector at the 
NSLS (beamline X26C) with 60 s exposure, 0.5° oscillation and 200 mm crystal to 
detector distance, arcs indicate 2.4, 3.2, 4.7, 7.8 Å. c) An expanded and contrast 
adjusted view of the high resolution diffraction perpendicular to the rotation axis 
from (b).  
 
 
3.1.4 Phase Problem in Crystallography (Background) 
In the standard crystallographic experiment a crystal is positioned in a beam of 
monochromatic X-ray radiation. X-rays passing through the crystal will cause the 
electrons of the molecules to oscillate. These oscillating charges then emit X-ray 
radiation of the same wavelength in all directions. A crystal consists of a periodic 
arrangement of molecules where repeating units, the so-called unit cells, form a three-
dimensional lattice. Because of this periodicity, the waves scattered by the atoms in all 
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unit cells will only interfere constructively in certain discrete directions. This leads to the 










where ar , b
r
, and cr  are the translation vectors of the crystal lattice, Laue-indices h1, h2, 
and h3 are integers and S
r
 is called the diffraction vector. An alternative way to describe 
diffraction is to consider a diffracted beam as being reflected by a plane hkl through the 
endpoints of vectors ar  / h, b
r
/ k and cr / l. (Miller indices h, k, and l are related to the 
Laue indices: h1 = nh, h2 = nk and h3 = nl, n being an integer). Diffraction only occurs if 
the angle θ of the incident beam with the lattice plane hkl satisfies Bragg’s law (3.2): 
 
λθ ndhkl =)(sin2     (3.2) 
 
where dhkl is the distance between adjacent lattice planes hkl and λ is the wavelength of 
the incident beam; integer n is called the order of the reflection. The direction of 
diffraction vector )(hklS
r
 is normal to the reflecting plane hkl and its length | )(hklS
r
| is 
equal to 1/dhkl. The endpoints of all vectors )(hklS
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form a three-dimensional lattice with 
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= ,  where V is the volume of the unit cell), the so-called reciprocal lattice. 
This lattice allows )(hklS
r
 to be calculated in a convenient way from (3.3): 
***)( clbkahhklS r
rrr
++=    (3.3) 
 
The experimentally measured intensity of reflection hkl depends on the distribution of the 
electrons in the unit cell. The electron density, ρ (xyz) is proportional to the square of the 
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with x, y and z being fractional coordinates. By inverse Fourier transform, the electron 
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From the electron density distribution, an atomic model of the molecules in the unit cell 
can be constructed. However, the structure factor, F (hkl), in equation 3.6 is complex 
quantity with an amplitude and a phase: 
 
( ))(exp)()( hklihklFhklF ϕ=    (3.6) 
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From the standard monochromatic experiment, amplitude F (hkl) can be derived from the 
measured intensity, but all information about phases )(hklϕ is lost. Therefore, the 
electron density distribution cannot be constructed directly using equation 3.5. This 
problem is known as the crystallographic phase problem. 
 
3.1.4.1 Ab initio Phasing Methods (Background) 
In ab initio phasing, phase estimates are obtained from a single set of structure factor 
amplitudes, without using any of the experimentally determined intensity differences. In 
this case, the phase problem may be overcome by incorporation of additional, a priori 
available knowledge.  
 
1) Direct Methods  
Even the simplest form of prior knowledge, the expectation that the electron density 
is non-negative and consists of separated atoms throughout the unit cell, leads to 
statistical relationships among the structure factors that can be used to solve the phase 
problem. In the 1950’s, Karle and Hauptman defined a functional form to express these 
relationships and thereby opened the field of direct methods (Karle & Hauptman, 1950). 
With recent advancements, direct methods are routinely used to solve thousands of 
structures consisting of up to 250 non-hydrogen atoms every year. The use of direct 
methods in protein crystallography has been limited because of the requirement of atomic 
resolution X-ray data and low phase reliability for the large number of atoms in the unit 
cell (Hauptman, 1997). Recently, programs like Shake-and-Bake have been used to solve 
substructures containing 2000 non-hydrogen atoms but high resolution data is still a 
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requirement. The program differs from the conventional direct method procedures in 
repetitively and unconditionally alternating the reciprocal-space phase refinement 
(shaking) with density modification (baking), which is then used to impose phase 
constraints in real space (Weeks et al., 1993; Sheldrick & Gould, 1995) . 
 
2) Low Resolution Phasing 
Several attempts have been made to solve the phase problem by first locating the 
protein molecular envelope in the unit cell by only using the lowest resolution reflections. 
Many selection criteria based on electron density histograms and connectivity properties, 
statistical likelihood, atomicity etc. have been developed to select the best set of phases 
from a large number of random trial sets (Podjarny & Urzhumtsev, 1997). A common 
feature of such criteria is that they do not unambiguously judge the phase quality at low 
resolution. Nevertheless, the selection of the phase sets with best criterion values 
increases the ratio of good phase sets in the ensemble considered. An approximate 
solution of the phase problem may then be found by averaging the selected phase sets. 
Cluster analysis of the selected phase sets and averaging within clusters allow further 
improvement of this solution (Lunin et al., 1998). These methods are important where the 
knowledge of the low resolution envelope is needed to solve the high resolution phase 
problem. For example, in molecular replacement, the approximate knowledge of the 
position and orientation of the molecule is helpful (Lunin et al., 2000). The low 
resolution ab initio methods have also proved helpful in obtaining the low resolution 
image of the large molecular complexes. For example, these methods were used to phase 
the 50S ribosomal subunit from Thermus thermophilus to 40 Å resolution (Urzhumtsev et 
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al., 1996). The low resolution methods may also be important for crystals, which do not 
diffract to high resolutions especially those of viruses (Lunin et al., 2000). Recently, low 
resolution methods have been coupled with averaging and density modification methods 
to further improve the quality of phases (Urzhumtsev et al., 2000). 
 
3) Molecular Replacement Method 
A much more common method of ‘ab initio’ phasing in protein crystallography is 
molecular replacement. In molecular replacement (Rossmann, 2001) a known structure of 
the homologous protein having high sequence identity (30% or greater) is used as prior 
phase information. Mathematically, the structure factor hklF
r
 is characterized by an 
amplitude | hklF
r
| and a phase angle ϕhkl. For an unknown structure, the amplitude can be 
obtained by measurement of the reflection intensities from the X-ray diffraction data 
(3.7): 
Ihkl, obs = | obshklF ,
r
|2 = Fobs2                                                          3.7 
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=                                       3.9 
 
Combining observed structure factors | obshklF ,
r
| form equation 3.7 and phase angles ϕcalc 
from equations 3.8 and 3.9, an electron density map for the biomolecule of interest can be 
calculated as follows: 
 
∑∑∑ −++−= ])(2[1),,( calclzkyhxiobs eFVzyx
ϕπρ           3.10 
 
Molecular replacement phasing algorithms obtain phase information by correctly 
placing the known model in the crystal lattice of the unknown structure. Traditionally, 
this problem was broken down into two three-dimensional search problems. Using 
Patterson search methods, first the correct orientation is determined, followed by a search 
for the correct translation vector (Rossmann & Blow, 1962). Recently, programs 
performing complete (Sheriff et al., 1999) or directed (Kissinger et al., 1999; Glykos & 
Kokkinidis, 2001) six-dimensional searches have been developed. Another recent 
development is the application of maximum likelihood to molecular replacement, which 
may allow the positioning of molecules with significantly lower homology (Randy, 
2001). In the case of weak phasing power of the molecular replacement solution, model 
bias is a major problem. Methods like SIGMAA (Read, 1986) and simulated annealing in 
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combination with maximum likelihood refinement (Adams et al., 1999) are helpful in 
removing model bias to some extent. More recent developments like prime and switch 
phasing in RESOLVE are proven to remove model bias. The method uses statistical 
density modification to remove model bias without including the phase information from 
the model, which was used for initial map calculations (Terwilliger, 2004). 
 
3.1.4.2 Experimental Phasing (Background) 
 
1) Single / Multiple  Isomorphous Replacement Methods (SIR/MIR) 
In macromolecular crystallography, it is common practice to solve the phase problem 
using additional experimental information (Drenth, 1999). In SIR or MIR methods, 
protein crystals are soaked in one or more solutions containing ‘heavy’ atoms. In the 
optimal case, this leads to specific binding of the heavy atoms to the protein molecules 
but the soaked crystals remain isomorphous to the native crystal. The differences in 
scattered intensities of the native and soaked crystals are significantly contributed from 
scattering of the heavy atoms and these differences can be used (for instance) to compute 
a Patterson map. Because there are only a few heavy atoms, such a Patterson map is 
relatively simple and easy to deconvolute. Alternatively, direct methods can also be 
applied to the intensity differences. Once the location of the heavy atoms in the crystal is 
determined, their contribution (FH1) to the structure factors of the isomorphous derivative 
crystal (FPH1) can be computed. If heavy atom binding does not alter the protein structure 
then FPH1 can be described as follows: 
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FPH1 = FP + FH1                                               3.11 
 
In the above equation phase and magnitude of FH1 are known but for FPH and FP only 
the magnitudes are known. In the Harker construction (Figure 3.2), the circle in green 
represents all the possible phases for FP (structure factor for native protein). The radius of 
the circle is equal to |FP|. After the first derivative is made with heavy atom H1, the 
possible phases for the derivatized protein crystals FPH1 can be represented by red circle. 
The structure factor from native protein FP, has two possible solutions, a vector pointing 
towards A or vector pointing towards B (where the circle in red with the radius of | FPH1| 
intersects with the green circle). The phases for the second derivative can be represented 
by the circle in cyan, which has radius equal to | FPH2|. Combining the phase information 
from both the derivatives, the phase angle for the unknown protein can then be 
unambiguously calculated. The final vector for protein of interest is represented by RFP, 
where both the circles (in red and cyan) intersect at a common point A (Blundell & 
Johnson, 1976) (Figure 3.2). Since phases are derived by analyzing more than one 





Figure 3.2 Harker construction for MIR method 
 
 
2) Multiple /Single Wavelength Anomalous Dispersion 
Many heavy atoms absorb X-ray radiation at wavelengths that are typically used 
in protein crystallography (0.6 - 2.0 Å). The absorbance of X-ray photons gives rise to 
anomalous diffraction. In anomalous scattering methods, the intensity differences 
between Friedel pair reflections hkl and -h -k -l (the so-called Bijvoet differences) at a 
single wavelength (SAD) can be used to calculate phase estimates.  
 
The continuous tunability of synchrotron radiation sources has made it convenient to 
exploit yet another signal: dispersive intensity differences between data collected at 
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different wavelengths. In multiple-wavelength anomalous dispersion methods, MAD 
(Hendrickson & Ogata, 1997), a combination of the anomalous and dispersive signals 
allows phase determination from a single crystal. The basic idea is to locate the 
anomalous scattering atoms within the unit cell (those contributing to FA) and use their 
position to calculate the corresponding phase angle A. The MAD phasing equations 
(Karle, 1980) can then be used to generate an estimate for  (difference in phase angle 
between normal and anomalous scattering components) and FT (the normal scattering 
component of all the atoms). In the simplest case this estimate is then used to the 
calculate phase of the FT, which is given as + A. A Fourier transform of the 
amplitudes FT and phases (  + A) yields an electron density map corresponding to all 




Figure 3.3 †† The vector diagram for calculating phases from MAD data set.  
represents the total observed scattering amplitude from the diffraction 
measurement at wavelength , which is unknown. FT is the normal scattering 
component of all atoms whereas FA is the anomalous scattering contribution from 
all atoms.  denotes the difference in phase angle between normal and anomalous 
scattering components. 
  
                                                 
†† Figure adapted from http://www.bmsc.washington.edu/scatter/MAD_1.html 
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MAD phasing has become increasingly popular due to the possibility to 
biosynthetically introduce anomalous scatterers into the protein itself (Ogata, 1998). In 
particular the Eschericia coli bacterium is used to substitute methionine for 
seleniomethionine. This yields anomalously scattering molecules with essentially equal 
structural properties compared to the native protein. Recently, density modification 
methods have been applied successfully to substitute the need for dispersive signals, 
allowing phasing by anomalous scattering using only a single wavelength, SAD (Wang, 
1985). 
 
3.1.5 Molecular Replacement Efforts to Solve ES* 
cDNA analysis of NAO identified it as a new member of acyl-CoA 
dehydrogenase (ACAD) superfamily (Daubner et al., 2002). The ACAD superfamily 
consists of different chain length acyl-CoA dehydrogenases (Kim & Miura, 2004), acyl-
CoA oxidase I and II (ACOs) (Pedersen & Henriksen, 2005; Nakajima et al., 2002)  and 
acyl-ACP dehydrogenase (Watanabe et al., 2003). NAO shares overall low sequence 
identity (21- 25%) with ACADs and BLAST searches did not return ACOs as possible 
homologs. ClustalW alignments showed that NAO only has 7 - 9% similarity with ACOs 
(Fitzpatrick et al., 2005). Since molecular replacement requires high sequence identity 
protein homologs, medium chain acyl-CoA dehydrogenases (MCAD), which share 25% 
sequence identity with NAO were chosen as molecular replacement search models. 
Cross-rotation searches were performed with polyalanine models of the monomer as well 
as a tetramer of pig and human MCAD using CNS v1.1 (Brünger et al., 1998a).  Low 
resolution data between 15 to 4 Å resolutions was used to search for the NAO molecular 
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envelop in different orthorhombic space groups (P222, P2221, P21212 P212121). 
Translation searches were performed using the top ten hits from the cross-rotation results. 
The searches gave a maximum correlation co-efficient of 15% and a minimum 
correlation co-efficient of 4.8% depending upon the molecular search model used. Since 
none of the molecular replacement results yielded reasonable correlation co-efficient or 
Rfactor, phasing efforts were shifted to experimental phasing techniques for solving the 
three dimensional structure of ES*. 
 
3.1.6 MIR Efforts to Solve ES* Crystal Structure 
In efforts to use MIR methods for phasing ES*, the native protein crystals of ES* 
were derivatized with Au and Pt salts. The crystals of the ES* derivatives diffracted to a 
maximum resolution of 2.5 Å and were also isomorphous, as suggested by the Riso 
values. The position of heavy atoms calculated using SOLVE v. 2.0.3 (Terwilliger & 
Eisenberg, 1983; Terwilliger et al., 1987) did not yield interpretable maps, which led to 
the conclusion that heavy atom sites were not localized. Since MIR trials for ES* were 
not successful, the data collection and analysis details are not included in this chapter. 
 
3.1.7 MAD Data Collection and Processing of SeMet-ES* Crystals 
SeMet-ES* crystals were mounted in a nylon loop and flash frozen in liquid nitrogen. 
Fluorescence scans of a high diffraction quality crystal were collected at the K absorption 
edge of selenium. An optimized scan was processed using CHOOCH (Evans & Pettifer, 
2001) and experimental f’ and f’’ (scattering factor and its imaginary part) plots were 
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calculated as a function of X-ray energy (Figure 3.4). A three wavelength SeMet MAD 
dataset collection strategy was designed based on f’ and f” plots. Since the largest signal 
comes from the wavelength with maximal f’’, the peak data set was collected at 0.9794 
Å. An additional wavelength, which was 100 eVs away from the absorption edge, was 
selected as a remote wavelength (0.9611 Å). The remote data set was collected before the 
inflection data set because the crystal showed signs of radiation decay in SCALEPACK 
analysis (Otwinowski & Minor, 1997). The inflection wavelength was selected to have a 
maximal |f'| value and therefore an inflection data set was collected at 0.9795 Å. At Each 
wavelength, 360 ° phi rotation was collected in order to ensure the collection of Bijvoet 
pairs with great redundancy. Each frame was collected with either 8 or 10 sec exposure 
time and 0.4 ° - 0.6 ° oscillation ranges. The crystal to detector distance was either 200 or 
250 mm. All the MAD experiments were done at beamline 17-ID operated by IMCA-
CAT at the APS using ADSC Q210 detector.  
 
All the three wavelength data sets were separately processed and scaled in MOSFLM 
/ SCALA routines from the CCP4 suite of programs (Powell, 1999; Evans, 1997). Since 
the data sets at each wavelength were collected with high redundancy (~13 overall), the 
anomalous signals were kept separate during scaling and merging. To deduce the quality 
and phasing potential of SeMet derivative, Normal Probability Analysis of three 
wavelengths was performed using FHSCALE and SCALEIT programs in CCP4. SCALEIT 
analysis showed that the dispersive differences were smallest between peak and inflection 
(normal probability for acentric = 1.357) and largest between inflection and high energy 
remote (normal probability for acentric = 2.099). The data analysis also suggested that 
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anomalous differences (FpHi+ v. FPHi-) were highest for peak data set (normal 
probability for acentric = 1.934). The values for Normal Probability Analysis were well 










































3.1.8 Location and Refinement of 52 Selenium Sites 
Data integration and scaling statistics of the SeMet-ES* crystal suggested an 
orthorhombic space group but intensity v/s hkl plots did not show a clear pattern of 
systematic absences. Therefore, the screw axis and space group could not be determined 
unambiguously. Space groups P222, P2221, P21212 P212121 with a, b, c cell convention 
and other combinations with a having the screw axis, b having the screw axis, a and b 
having the screw axes, b and c having the screw axes, showed reasonable overall Rsyms 
values (~10%). Space group ambiguity coupled with a large number of expected 
selenium sites (52) complicated the phasing problem. In order to deal with this 
combination of problems, a single wavelength peak data set was indexed in lowest 
symmetry space group (P222). The reason for selection of single wavelength peak data 
set in the beginning was to maximize the signal-to-noise ratio in order to have a 
reasonably large ΔF (difference in structure factor) value. In principle, the peak 
wavelength has the largest expected difference in F+ and F-, since the peak data set is 
collected at f” maxima. The choice of starting with a SAD data set also eliminated the 
problem of decreasing signal-to-noise ratio in subsequent data collection runs because of 
the radiation damage.  The .mtz file obtained after indexing in P222 space group was 
reindexed in all possible space groups using a CCP4 script. Each possible space group, 
was searched for Patterson cross peaks for selenium atoms. An automated program 
(SOLVE v. 2.03) was used to solve the patterson functions (Terwilliger & Eisenberg, 
1983; Terwilliger et al., 1987). Several SOLVE runs were started with different .mtz files 
between resolution range of 20 – 3 Å. The program gave the position of heavy atom sites, 
which were then evaluated based on Figure of Merit (FOM) and a statistical z score 
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(Terwilliger & Berendzen, 1997, 1999). SOLVE found a maximum number of selenium 
sites (25) in space group P212121. The results in the space group P212121 had the highest 
FOM = 0.43 and a z score of 169.53 in contrast to other space groups, which had low 
FOM ~ 20 and z scores ~ 25. Although a high FOM and z score value clearly pointed 
towards P212121 space group, electron density maps constructed using the phase 
information from SOLVE were not interpretable. The density modification in 
RESOLVE_huge v. 2.06 (Terwilliger, 2001), which was explicitly compiled for large 
number of reflections, improved the FOM to 0.66 but did not give interpretable maps. 
The 25 selenium sites found from the SAD data analysis in SOLVE were input in 
ADDSOLVE (a routine in SOLVE_giant v. 2.06) to find additional selenium sites. Two 
separate ADDSOLVE runs were started at 3 Å resolutions. The first one used a 3 
wavelength MAD data set scaled in SCALEIT and the second one used a 2 wavelength 
MAD (peak and remote) data set. Both the runs took more than a month to run on SGI 
(IRIX 6.5), which had 1GB swap space and dual 550 MHz processors. ADDSOLVE 
results with 3 wavelengths found a total of 30 selenium sites with the correct hand (FOM 
= 0.45 and z score = 251). These sites along with another 22 sites, which were found 
from analysis of residual maps in SHARP v. 3.0.15 (de LaFortelle & Bricogne, 1997) 
resulted in interpretable maps. The phases were then extended to the highest resolution 
shell (2.2 Å) using SHARP v.3.0.15. 5 % of the total reflections were taken out for cross 




3.1.9 Density Modification and Model Building 
Since protein crystals typically contain 30-70% solvent, organized in channels of 
unordered water molecules, solvent flattening procedures like DM (Cowtan & Main, 
1996), SOLOMON (Abrahams & Leslie, 1996) or RESOLVE (Terwilliger, 2002) often 
improve the quality of maps. In SOLOMON (CCP4), the electron density is constrained 
towards a flat solvent region, and this real-space density modification is iterated with a 
phase-combination step in reciprocal space. DM (CCP4) uses a similar iterative 
procedure in histogram matching where prior information in the form of expected density 
histograms is applied as constraints on the electron density map. RESOLVE, another 
density modification program, applies maximum-likelihood principle to do solvent 
flattening. The highest quality solvent flattened maps for SeMet-ES* to 2.2 Å were 
obtained from SOLOMON (Abrahams & Leslie, 1996) from CCP4. The FOM of the 
solvent flattened maps had a phenomenal value of 0.94 and the maps were of superb 
quality. Initial protein backbone tracing was done using the pattern recognition algorithm 
in RESOLVE_huge v.2.06 (Terwilliger, 2002). The remaining protein model was built 
manually in O using 1.5 σ level 2mFo - DFc electron density (Jones et al., 1991) maps. At 
first, the model building in one chain was completed. The remaining three chains in the 
asymmetric unit were traced by applying the symmetry matrices generated in CCP4. 
Rotamers for the amino acid side chains were fitted using O library files. The N5-(2-
nitrobutyl) modified FAD was manually modeled in the electron density using O 
dictionary, connectivity, torsion and stereo files generated from PRODRG server 
(Schuettelkopf & van Aalten, 2004).   
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3.1.10 Refinements (Background) 
The initial protein model generally contains errors and must be optimized. The goal 
of crystallographic refinement can be formulated as finding the set of atomic coordinates 
that results in the best fit of the observed structure factor amplitudes and the amplitudes 
calculated from this model. In conventional least-squares refinement (Drenth, 1999), this 









   (3.12) 
 
where whkl is a weighting factor, k is a scale factor and the calculated structure factor 
amplitude |Fcalc| is dependent on the parameter set of the model. Calculation of 
derivatives of |Fcalc| towards the model parameters allows application of gradient-driven 
optimization techniques to minimize this function. The refinement converges readily to 
the correct solution after many cycles if there are no false minima and the starting model 
is not drastically different from the actual structure (Sussman et al., 1977). 
 
However, the starting model is usually not very similar to the actual macromolecular 
structure. The reason for this is the poor observations (intensities) to parameters (three 
atomic positions x,y,z, one isotropic temperature factor B and occupancy for each non-
hydrogen atom) ratio at the resolutions to which macromolecular crystals normally 
diffract (1.5 - 3.5 Å). To avoid over-fitting of the limited amount of experimental data, 
either more observations are added in the form of restraints, or the number of parameters 
are reduced by constraining the model in different ways (Sussman et al., 1977). Typical 
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set of restraints come from the prior geometrical knowledge, which is expressed in the 
form of expected bond lengths, bond angles and van der Waals contact distances. 
Restraints are generally defined to conserve the planarity of planar groups or to maintain 
the chirality of chiral centers. The restraints are then entered as terms in the refinement 
target, which is defined as follows: 
 
rayXgeom EawEE −+=     (3.13) 
 
with Egeom being expressed as follows: 
 







geom wrrwE θθ    (3.14) 
 
where bond distances rbond, angles θangle, and other geometric parameters of the protein 
model like torsion angles, planarity of rings etc. are restrained towards their ideal values 
using weights w. Weight wa (in equation 3.13) for the crystallographic term is chosen 
such that approximately equal gradient contributions from both sides of the combined 
target function result. Application of the constraints is only justified if X-ray diffraction 
data is of moderate resolution (dmin 2.5 Å). The number of parameters is reduced by either 
constraining certain groups of atoms or even an entire molecule to a rigid body. This 
limits the degrees of freedom to torsion angles, thus resulting in a further improved 
observation-to-parameter ratio. The rigid body refinement might bring a model within a 
radius of convergence for least-squares. A torsion-angle parameterization of protein 
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molecules has been implemented in the CNS program (Brünger et al., 1998a; Rice & 
Brünger, 1994).  
 
Molecular dynamics simulations allow greater energy barriers to be overcome in the 
positional parameter variation which helps to avoid the refinement becoming trapped in 
local minima. The technique simulates possible energetically allowed structures for a 
given temperature and pressure. The process is repeated after a short time step with the 
atoms in the new positions until a minimum potential energy is reached describing the 
dynamic behavior of the atoms. The temperature can be raised in order to overcome 
energy barriers and then decreased slowly to approach the energy minimum (a process 
called simulated annealing (Kirkpatrick et al., 1983). The temperature during the 
simulated annealing refinement is a parameter describing the height of the local energy 
barriers that the refinement can overcome. Hence, simulated annealing refinement has a 
significantly larger radius of convergence than the restrained least-squares refinement. 
Movements greater than 5 Å can be achieved (Brünger et al., 1990; Rice & Brünger, 
1994). 
 
Major advances in refinement have been made by the formulation of maximum 
likelihood target functions (Bricogne, 1997). In contrast to least-squares methods, 
maximum likelihood provides a statistically valid way to deal with errors and 
incompleteness of the model. A general approach is to represent the resolution-dependent 




A EE .=σ     (3.15) 
 
where σA values are calculated in resolution bins and Eobs and E calc are observed and 
calculated normalized structure factors. Since the phases of E obs are unknown, σA values 
need to be estimated. Cross-validation, initially introduced to monitor over-fitting of the 
data by calculation of a free R-factor (Brünger, 1997), plays an important role in the 
estimation of σA values (Adams et al., 1999). In cross-validation, typically 5-10% of the 
data (the test set) is kept outside the refinement. Estimation of σA values based on these 
test set reflections avoids serious over estimation resulting from over-fitting of the data. 

































Similar equations are derived to calculate the probability to observe structure factor 
amplitude |Fobs|, given calculated structure factor Fcalc and the measurement error in |Fobs|. 
Maximum likelihood refinement aims to maximize the likelihood of measuring the set of 
observed structure factor amplitudes, given the calculated structure factors of the model. 
 
A recent development in protein structure refinement is the possibility to model 
anisotropic motions of complete domains by TLS-parameterization for the translation, 
libration and screw-rotation displacements of pseudo-rigid bodies (Schomaker & 
Trueblood, 1968) as implemented in the maximum likelihood refinement program 
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REFMAC5 (Winn et al., 2001). Despite the developments mentioned above, the radius of 
convergence of protein structure refinement remains limited and in current practice 
refinement cycles still need to be iterated with time-consuming rebuilding steps where the 
model is improved manually by interpretation of electron density maps. 
 
3.1.11 Refinements of ES* Crystal Structure 
After building significant portions of the ES* homotetramer in the asymmetric unit, 
rigid body refinements were performed between resolution range of 40 – 2.2 Å. All the 
residues of the homotetramer in the asymmetric unit were specified as one rigid body. 
Molecular topology file for the refinements was generated using generate_easy routine in 
CNS. Initial refinements were carried out against the merged Fobs from all the three MAD 
wavelengths. A maximum likelihood target including amplitudes and phase probability 
distribution (Brünger et al., 1998b) was chosen in initial refinements. Twenty 
minimization steps of rigid body refinement were performed along with initial isotropic 
B-factor refinement and bulk solvent correction. At this stage of the refinements, the N5-
FAD adduct was not modeled into the electron density maps. After rigid body 
refinements Rcryst (Brünger, 1997) dropped to 46.68 % from an initial value of 52.84 % 
whereas Rfree(Brünger, 1992) (calculated from the 5 % of the total reflections randomly 
selected from the entire MAD data set) dropped to 46.55 % from a starting value of 52.72 
%.  Since most of the model fitted well into the electron density (2mFo - DFc) maps, 
simulated annealing runs were performed only with torsional molecular dynamics (Rice 
& Brünger, 1994). The Cartesian molecular dynamics was constrained in all the four 
cycles of simulated annealing. The starting protein model was heated to high temperature 
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of 10,000 K for annealing procedure with a step size of 25 K. The model was slow cooled 
to a final temperature of 100 K. The Rcryst after the final run of simulated annealing 
dropped from 44.92 % to 28.06 % whereas Rfree dropped from 44.21 % to 31.56 %. After 
simulated annealing, B factors were refined by choosing the whole homotetramer as one 
group. Individual B factors were also refined afterwards. The B factor refinements 
dropped the Rcryst to 25.31 % and Rfree to 28.9 %.  
 
Unambiguous electron density for N5-(2-nitrobutyl) moiety was observed at 5 σ level 
in mFo - DFc maps. The N5 modified adduct was modeled using parameter and topology 
files generated from PRODRG server (Schuettelkopf & van Aalten, 2004). Both cis and 
trans form of the nitrobutyl moiety were modeled into the electron density in separate 
trials. The refinements of cis model showed negative electron density at 3 σ on the 4th 
carbon atom. The trans form showed no negative density in mFo - DFc maps C4 atom of 
the nitrobutyl moiety was replaced by electron dense nitro group. The cis form of the 
nitrobutyl moiety was also ruled out because the nitro group in this conformation was too 
close to side chain oxygen of the Ser171 and O4 of the isoalloxazine ring. Although 
refinements were converging as evident from the decrease in the Rcryst values, all the 
seleniums showed negative electron density at 3 σ levels in mFo - DFc maps. The 
problem was partially solved by using anomalous libraries (generated in CNS using 
experimental f’ and f’’ values from the fluorescence scans of SeMet) and refining the 
calculated structure factors against the observed structure factors from the peak data. 
Apparently, the selenium signal was bleached over the period of data collection and the 
intensity of selenium signal was proportional to the wavelength at which the data was 
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collected.  Out of 52 selenium sites, 24 selenium sites still had negative density at 3 σ 
level but had very low B factors (~28 Å2). In order to account for the negative density on 
selenium atoms, B factor restraints were relaxed to the following values: 
1) Main chain bonds = 2.0 Å2 (default = 1.5 Å2) 
2) Main chain angles = 3.0 Å2 (default = 2.0 Å2) 
3) Side chain bonds = 4.5 Å2 (default = 2.0 Å2) 
4) Side chain angles = 6.0 Å2 (default = 2.5 Å2) 
Finally, the occupancy of selenium sites was refined using q_group routine in CNS v. 1.1. 
In later stages of refinements selenium occupancies were manually optimized by looking 
at the negative density features, which were still present in the mFo - DFc maps at 3 σ 
level.   
 
A total of 16 cycles of refine.inp were run in order to achieve a final Rcryst value of 
23.68% and Rfree of 26.72 %. A maximum likelihood function using amplitudes was 
chosen as target in the later stages of refinements. All the refinements were done using 
CNS v. 1.1. After the refinements had converged water molecules were added to the 
protein homotetramer using ARP/wARP (Perrakis et al., 1999) routine in CCP4. In first 
cycle a total of 400 water molecules were added with a sigma cut off of 4. In the second 
cycle, another 600 water molecules were added with ARP/wARP with sigma cut off of 
2.5. Water molecules with B factor greater than 45 Å2 were inspected manually using O. 
The difference features in the mFo - DFc maps overlapped with 2mFo - DFc maps were 
manually inspected to add or delete more water molecules. The final structure was 
refined with one homotetramer (1720 protein residues), 4 N5-FAD adducts and 694 water 
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molecules per asymmetric unit. The structure of ES* was refined with final Rfactor of 
20.16 % and Rfree of 23.22 % to 2.2 Å resolution. Secondary structure analysis was done 
using KSDSSP (Kabsch & Sander, 1983). 
 
3.2  Crystal Structure Determination of Oxidized Form of NAO  
 
3.2.1 Preparation and Purification of Natural and SeMet Enriched 
Form of Oxidized NAO  
Recombinant nitroalkane oxidase was expressed and purified from E. coli strain 
BL21 (DE3) transformed with pETNAO4 as previously described (Daubner et al., 2002; 
Valley & Fitzpatrick, 2003b). The purified enzyme was stored in 20 mM HEPES pH 8.0, 
1 mM EDTA, 5% glycerol and aliquots were flash frozen with liquid N2. Se-Met 
enriched NAO was obtained by expression in the methionine auxotroph E. coli B834 
(DE3) (Novagen) (Nagpal et al., 2004). A single colony of E. coli B834 (DE3) 
transformed with pETNAO4 was used to inoculate 5 ml of LB containing 100 µg/ml 
carbenicillin at 37 °C. After 8 hours, 1 ml of the starter culture was used to inoculate 50 
ml of a minimal media composed of the following (g/l except where noted): Na2HPO4, 
7.0; KH2PO4, 3.0; NH4Cl, 1.0; all amino acids, 0.1; adenine, 0.1; thiamine and riboflavin, 
0.002; carbenicillin, 0.1; MgSO4, 2 mM; CaCl2, 0.1 mM; and D-glucose, 22 mM. After 
12 hours at 37 °C, 4 ml of the step up culture was used to inoculate 1 liter (6X) of the 
same minimal media, except methionine was replaced with seleniomethionine at 0.1 g/l. 
When the absorbance at 600 nm reached 0.6, the temperature of the cultures was lowered 
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from 37 to 25 °C and IPTG was added to a final concentration of 0.25 mM. Cells were 
harvested after 8.5 hours of expression and Se-Met enriched NAO was purified by the 
normal protocol. The gene sequence for NAO predicts a 439 amino acid protein of 48162 
Dalton. The amino terminal methionine is cleaved by the expression host resulting in 13 
methionines per chain. Biophysical solution studies are consistent with a homotetramer-
homodimer equilibrium with a Ka for tetramerization of 8 x 10 6 M -1 (Gadda & 
Fitzpatrick, 1998).  
 
3.2.2 Crystallization of Oxidized NAO in Three Different Space Groups 
Needle shaped microcrystals were initially obtained from cryo screen HR-1 
(Hampton Research, Aliso Viejo, CA ) with the hanging drop, vapor diffusion method. 
These conditions were optimized and diffraction quality crystals (form 1) were grown by 
mixing 2 µl of 10 mg/ml protein solution (10 mM sodium cacodylate, pH 7.5) with 2 µl 
of reservoir solution containing 25% w/v PEG 4000 and 35% v/v glycerol, sodium 
cacodylate trihydrate (200 mM, pH 7.5), 1 mM spermine hydrochloride (Spm-Cl) at 4 °C 
(Figure 3.5 a). The crystals typically grew within 10 d. NAO in crystal form 2 was 
grown from conditions containing 25% w/v PEG 4000 and 30% v/v glycerol, sodium 
cacodylate trihydrate (200 mM, pH 7.5), 1mM Spm-Cl and 8% w/v of 1,6-hexanediol at 
4 °C. Single, square shaped crystals (0.15 x 0.12 mm) were obtained by mixing 2 µl of 8 
mg/ml of protein with 2 µl of reservoir solution after 25-30 d equilibration at 4 °C 
(Figure 3.5 d). Crystal form 3 was from SeMet-NAO enzyme grown from conditions 
similar to crystal form 1 except the protein was incubated at 4 °C for 5 h with 10 mM 
dithiothreitol prior to setting up the drop (Figure 3.5 g). The SeMet-NAO crystals 
 68
typically grew within 2 weeks. For each crystal form, single crystals were mounted 
directly in nylon loops since no additional cryoprotectant was necessary, and they were 
flash frozen by quick submersion into liquid N2 (Nagpal et al., 2004).  
 
3.2.3 Data Collection & Scaling of Oxidized NAO Crystals (Form II & 
III)  
X-ray diffraction data from crystal form II were collected at the SER-CAT sector 
of APS on beamline 22-ID using a marCCD 165 detector. Each image was collected 
using 1.0 Å x-rays with a crystal to detector distance of 250 mm. A total of 180° of phi 
rotation was collected with a 2 sec exposure time per frame and 0.5º oscillation range 
(Figure 3.5 e, f). A three wavelength MAD dataset on SeMet-NAO was collected at SER-
CAT using a mar225 detector. A high sensitivity fluorimeter (Röntec USA Inc., Carlisle, 
MA) was used to separate the arsenate peak from the selenium signal. Forward and 
inverse beam datasets (110° of 30 phi rotation, each) were collected at the peak (0.9792 
Å), inflection (0.9794 Å) and remote (0.9686 Å) wavelengths. Each frame was collected 
with an exposure time of 4 s and 1.0° oscillation range (Figure 3.5 h, i). The crystal to 
detector distance was 270 mm (Nagpal et al., 2004). Datasets for crystal form III were 
processed with HKL-2000 (Otwinowski & Minor, 1997). The datasets for crystal form II 
were processed with MOSFLM (Powell, 1999) and SCALA (Hamilton et al., 1965). The 
three wavelength MAD dataset of SeMet-NAO was further scaled and analyzed with 




Figure 3.5 Crystals photographed without polarization of nitroalkane oxidase 
(NAO) in a) crystal form 1 (0.25 X 0.15 mm), d) crystal form 2 (0.15 X 0.12 mm).  
The x-ray diffraction pattern at 100K with rotation about the vertical axis (arrows) 
collected with b) ADSC Quantum 4 detector at BIOCARS beamline 14-BMC from 
(a) with 60 s exposure, 0.3º phi rotation, 400 mm crystal-to-detector, arcs indicate 
(3.5, 4.6, 6.9, 13.8 Å), 2θ detector offset = 10.7º; e) from (d) but collected with a 
marccd 165 detector at SER-CAT beamline 22-ID, 2 s exposure, 0.5º phi rotation, 
250 mm crystal-to-detector distance, circles indicate (3.4, 4.5, 6.8 and 13.6 Å). An 
expanded and contrast adjusted view of the high resolution diffraction 
perpendicular to the rotation axis for: c) from (b), 2.5 Å at the edge, f) from (e), 3.4 
Å at the edge. 
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Figure 3.5 Continued g) SeMet enriched crystals of oxidized NAO photographed 
without polarization in crystal form 3 (0.3 X 0.1 mm).  The x-ray diffraction pattern 
was collected at 100K with rotation about the vertical axis (arrows). h) was collected 
from (g) with 4 s exposure collected with a marccd 225 detector at SER-CAT, 1.0º 
phi rotation, 270 mm crystal-to-detector distance, circles indicate (2.4, 3.3, 4.9 and 
9.8 Å).  An expanded and contrast adjusted view of the high resolution diffraction 
perpendicular to the rotation axis form (h) is shown in (i). The resolution at the edge 
of the detector was 2.8 Å. 
 
 
3.2.4  Data Collection and Processing Strategy for 485 Å Long Cell 
Edge Crystals of Oxidized NAO (Form I) 
§Oxidized NAO crystallized easily in form I and often diffracted to very high 
resolution (1.6 Å), which encouraged us to vigorously pursue this crystal form. However, 
the diffraction pattern observed with our in-house Cu Kα X-rays was very streaky, even 
                                                 
§ Reformatted from http://www.nsls.bnl.gov/newsroom/science/2005/03-Orville.htm (Authors: Nagpal, A. 
and Orville, A.M.) 
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at the maximum crystal to film distance (Figure 3.6). This prompted us to carefully alter 
our crystallization conditions, cryo-conditions, freezing processes and general 
manipulation techniques. However, the diffraction patterns were always disappointing 
relative to the visual qualities of the crystals. In contrast, our first diffraction images 
obtained at X26C gave different results (Figure 3.6). The NAO crystals diffracted to 
beyond 1.6 Å resolution in space group P3221, but with unit cell dimensions of a = b 
=104 Å, c = 485 Å. Since the observed X-ray diffraction pattern has a reciprocal 
relationship with the unit cell dimensions of the crystal in real space (Figure 3.7), the X-
ray reflections collected from NAO long cell edged crystals were always closely spaced. 
The close diffraction spots could not be resolved at home source (Rigaku IV++ X-ray 
generator) because of the long wavelength (CuKα 1.54 Å) and the limitations of the beam 
optics (Figure 3.6). In contrast, better beamline optics, shorter wavelength (0.9 Å) and 
good point resolution detectors at synchrotron beamlines resolved the diffraction spots.  
Along with the above mentioned parameters, large crystal to detector distance was also 
required for resolving the closely spaced spots. The large distance allowed the X-ray 
reflections to diverge from each other before they reached the detector. However, this 
also significantly decreased the maximum Bragg angle of reflections that reached the 
detector and thus the high resolution reflections was not collected. Because of this 
reciprocal relationship (Figure 3.7), the complete data set to high resolution could not be 
easily achieved. In order to collect a complete data set to high resolution, we visited 
several beamlines at APS and NSLS and tried different area detectors (mar165, ADSC 
Quantum 4, ADSC Q210, mar225, Bruker Proteum 300). Although area detectors like 
Bruker Proteum 300 had the maximum active area (300 X 300 mm) for data collection, 
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the point resolution function of the detector was not good enough to resolve the spots. 
Other data collection parameters like 2θ offsets and κ geometry were also optimized 




Figure 3.6 Expanded sections of the observed X-ray diffraction pattern collected 
from long cell edge NAO crystals with a detector distance of 400 mm. The data on 
the left was collected with Raxis IV++ X-ray generator at home where as the data on 







Figure 3.7 Ewald sphere construction showing the reciprocal relationship between real 
space unit cell and the observed diffraction pattern** 
                                                 
** reproduced from http://www.doe-mbi.ucla.edu/%7Esawaya/m230d/ 
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For the high resolution data of NAO, our strategy was to collect several data sets that 
differed with a vertical offsets (approximately equivalent to 2θ and to optimize the kappa 
geometry such that the long cell axis was approximately parallel to the crystal rotation 
axis and to fill in missing regions of reciprocal space. The data collection strategy, which 
finally led to structure solution of oxidized form of NAO consisted of three or four data 
collection sweeps using 0.90 Å X-rays and an ADSC Quantum 4 detector at the 
BioCARS beamline 14-BMC of the Advanced Photon Source (APS) at Argonne National 
Laboratory. First, the high resolution data was collected at κ = 0° and a total of 120° of 
phi rotation with 0.3° rotation per frame. The detector was vertically offset 150 mm and 
the crystal to detector distance was 400 mm. Next, kappa was rotated to ± 40° and omega 
sweeps of 100° total rotation were collected with the same vertical offset and detector 
distance. The detector was then moved to 80 mm vertical offset and 120° of phi rotation 
were collected with all of the other parameters as in the second pass. Finally, the low 
resolution data was collected with 100° of phi rotation in 0.3° rotation per frame with κ = 
0°, no vertical detector offset and a distance of 400 mm. Each frame was collected with 
an exposure time of 30 sec. Data sets were processed in HKL2000 and merged in 
SCALEPACK. Merging these data sets yielded overall 93.5% completeness and 80% 
completeness in the 2.07 Å resolution shell, but only 60% complete to 1.6 Å resolution. 
As of June 2005 only 172 x-ray structures (out of 314,34) deposited in the PDB contain a 
c axis unit cell edge greater than 480 Å. Moreover, only 17 of these structures were to at 
least 2.5 Å resolution. To our knowledge, the structure of oxidized form of NAO sets the 
highest resolution record for a large unit cell in the Protein Data Bank (PDB) (Nagpal et 
al., 2004).  
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3.2.5 Molecular Replacement Solution for Oxidized Form of NAO 
The data processing of the crystals in form I showed a pattern of systematic absences. 
Every third reflection was present (special condition l = 3n), which narrowed the space 
group choices to P31, P32, P3112, P3212, P3121, P3221, P62, P64, P6222, P6422. Out of 
these possibilities, reasonable Rsym (~7.6 %) were only observed for P31, P32, P3121, 
P3221 space groups. The possibility of the other trigonal and hexagonal space groups (l ≠ 
3n) was not totally eliminated because the observed pattern of systematic absences could 
also arise from non-crystallographic symmetry. Molecular replacement efforts were 
started in P31, P32, P3121, P3221 space groups. Because of the large unit cell Matthews 
co-efficient calculations (Kantardjieff & Bernhard, 2003) were reasonable for 4 – 12 
monomers per asymmetric unit. The statistical probability graphs for the solvent content 
calculations at 2 Å resolution suggested 4 – 8 molecules per asymmetric unit depending 
upon the space group chosen. A large number of molecular replacement runs were set up 
in MOLREP (CCP4) (Vagin & Teplyakov, 1997) to find 4 - 8 molecules per as 
asymmetric unit with ES* tetramer or monomer as search model. For preparing the 
search model, all the SeMet were changed to Met and FAD adduct and water molecules 
were removed. All the molecular replacement results were refined in order to evaluate the 
quality of the solution. 5% of the total reflections were isolated to cross validate the 
refined model (Brünger, 1992). The rigid body and restrained refinements were 
performed in REFMAC5 (Murshudov et al., 1997) using low resolution (3 Å) data. 
Results in all the space groups with varying number of monomers per asymmetric unit 
except for P3221 with 6 monomers per asymmetric unit gave an Rcryst value varying 
between (52.6 % - 36. 2%) and Rfree between the range of (57.1 % - 42.5% ). The best 
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molecular replacement solution was obtained using ES* monomer as a search model in 
P3221 with 6 monomers per asymmetric unit (correlation co-efficient – 62.3%). Rigid 
body and restrained refinement gave an Rcryst of 21.5 % and Rfree of 26.6 %. 
 
3.2.6 Model Building and Refinement Procedures for Oxidized Form of 
NAO 
The molecular replacement solution matched the experimental electron density maps 
(2mFo - DFc) and no significant model rebuilding was required. A total of 19858 protein 
atoms were manually inspected in  the model using O (Jones et al., 1991), which took a 
significant amount of time. Side chains and rotamers were adjusted using O library files. 
The FAD was modeled and refined using the O and REFMAC5 dictionary files created 
with PRODRG server (Schuettelkopf & van Aalten, 2004). Maximum likelihood 
refinements were carried against the Fobs calculated between resolution of 50 – 2.07 Å 
resolution using REFMAC5 in CCP4. A long tubular positive density at 3.5 σ (mFo - DFc 
maps) was observed in the active site of the three out of the six subunits in the 
asymmetric unit. Spermine, a weak competitive inhibitor of NAO ((Ki ~200 mM at pH 
8), which was present in the crystallization conditions, was fitted into the electron density 
using the  O dictionary files from the HIC-Up server (Kleywegt & Jones, 1998). The 
electron density for spermine in the three subunits was refined in REFMAC5 with an 
overall B factor of 40 Å2. After the refinements had converged, water molecules were 
added  using ARP/wARP  (Perrakis et al., 1999) routine in CCP4. In first cycle a total of 
500 water molecules were added with a sigma cut off of 4. In the second cycle, another 
800 water molecules were added with ARP/wARP with sigma cut off of 2.5. Water 
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molecules with a B factor greater than 45 Å2 were manually inspected using O. The 
difference features in the mFo - DFc maps overlapped with 2mFo - DFc maps were 
manually inspected to add/ remove water molecules, glycerols and PEG4000. The final 
refined model had 1.5 homotetramer (2580 protein residues), 1136 water molecules, 14 
glycerol molecules and 2 PEG4000 molecules per asymmetric unit. After adding all the 
ligands and water molecules a positive density feature to 3.5 σ level (mFo - DFc maps) 
became apparent in the active site of the C chain. A spermine molecule was modeled into 
the active site of C chain. Spermine molecules were refined to an overall average B factor 
of 46 Å2. The final structure of the oxidized NAO has two empty (Eox) and four inhibitor 
















This chapter describes data collection and phasing statistics of ES* and EI crystals. 
The statistical calculations were performed to assess the quality of X-ray diffraction data. 
Phasing statistics like Phasing Power and Rcullis were used to estimate the phasing 
potential of the derivative. Initially, heavy atom soaks with Pt and Au salts were used to 
derivatize ES* crystals. Although MIR (multiple isomorphous replacement) data sets had 
reasonable Rsyms (~8%) and Riso (the parameter used to describe the isomorphous 
differences between native and derivative crystals) values, the location of the heavy atom 
sites did not yield interpretable maps. The phasing power for MIR data sets was less than 
one, which led to the conclusion that heavy atoms in ES* derivatives were not localized 
and therefore could resolve the phase problem. Since MIR methods were not successful 
this chapter does not describe the data collection and phasing statistics for MIR data sets 
but only concentrates on the results from SeMet MAD data analysis. The quality of ES* 
and EI crystal structures was evaluated using Ramachandran Plots, temperature factor 
analysis and ESU (estimated standard uncertainity) values calculated form REFMAC5 
(Cruickshank, 1999). The three dimensional structures of ES* and EI were compared by 
calculating the r.m.s deviation plots using SUPERPOSE in CCP4 (Krissinel & Henrick, 
2004). A calculation of solvent accessible surface areas for all the residues in ES*, EI and 
Eox structures was done using CNS v. 1.1 (Brünger et al., 1998a). The surface 
accessibility of FAD and its atoms in different crystal structures of NAO was calculated 




4.1 Data Collection Statistics for ES* and SeMet-ES* Crystals 
The ES* form of NAO was successfully crystallized in both natural abundance and 
SeMet enriched forms, as described in experimental section.  The crystals were colorless 
suggesting the presence of the 5-(2-nitrobutyl)-1,5-dihydro-FAD adduct. To prevent 
conversion to active enzyme, all the crystal manipulations were done at 4 °C and all the 
diffraction data was collected from cryo-preserved crystals. A complete data native data 
set was collected to 2.5 Å resolution. Unit cell parameters and data collection statistics 
are presented in (Table 4.1). A very complete and highly redundant three wavelength 
MAD dataset was collected and analyzed for anomalous scattering from the selenium 
atoms in SeMet-ES* to 2.2 Å resolution (Table 4.1). Cell parameters were very similar to 
the native data set. Solvent content and Matthews coefficient analysis suggests the 
presence of one homotetramer per asymmetric unit (VM 3.35; 63.3% solvent) 
(Kantardjieff & Rupp, 2003; Matthews, 1968). Self rotation function analysis indicates 
the presence of 222 fold local symmetry, which is consistent with four subunits in the 





 Table 4.1 Data collection statistics for ES* and SeMet ES* 




(Inflection) Native ES* 
X-ray Source APS APS APS NSLS 





Wavelength (Å) 0.9794 0.9611 0.9795 1.0007 
Detector ADSC Q210 ADSC Q210 ADSC Q210 ADSC Q4 
Distance (mm) 200 200 250 200 
Exposure time (s) 8 8 10 60 
Resolution Range 
(Å) a 
40 – 2.2 
(2.32 – 2.2) 
40 – 2.64 
(2.78 – 2.64) 
40  – 2.85 
(3.00 – 2.85) 
50 – 2.3 
(2.42 – 2.30) 
Δ phi per image (°) 0.4 0.4 0.6 0.5 
Mosaic Spread  (°) ~ 0.55 ~ 0.55 ~ 0.56 ~ 0.3 
Space group P212121 P212121 P212121 P212121 
Unit Cell (Å), a  90.4 90.4 90.5 90.5 
b 163.9 163.2 163.9 164.0 
c 173.4 173.5 173.8 172.5 
Total Reflections 1496015 1023723 850177 789148 
Unique Reflections 130755 76209 61184 114527 
Multiplicity  11.4 13.4 13.9 6.9 
Completeness (%) a 99.9 (99.9 ) 99.9 (99.9) 99.9 (99.9) 99.9 (99.9) 
Anomalous comp. 
(%) 98.9 99.8 99.8         - 
Rsym a,b 0.105 (0.53) 0.106 (0.422) 0.097 (0.491) 0.133 (0.437) 
I/σ(I) a,c 6.0 (1.5) 5.4 (1.7) 6.8 (1.5) 5.0 (1.6) 
a Values for the highest resolution shell of data are given in parentheses.  b Rsym (I) gives the 
average agreement between the independently measured intensities such as ΣhΣi |Ii - I| / ΣhΣi I, 
where I is the mean intensity of the i observations of reflection h. c I/σ(I) is the root-mean-square 
value of the intensity measurements divided by their estimated standard deviation. 
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4.2 Phasing Statistics for SeMet-ES* Crystals 
ADDSOLVE subroutine from SOLVE_giant v. 2.06 (Terwilliger & Eisenberg, 1983; 
Terwilliger et al., 1987) was used to locate 30 SeMet sites in P212121 space group. The 
phasing results had an overall figure of merit (FOM = 0.45) and z score of 251. An 
additional 22 SeMet sites were located with SHARP (de LaFortelle & Bricogne, 1997) by 
analyzing residual maps based upon the 30 SeMet sites.  All 52 SeMet sites refined to 
convergence to 2.2 Å resolution in SHARP (Table 4.2). Solvent flattening in SOLOMON 















4.3 Evaluation of the Model Quality (ES*) 
The final model consists of one homotetramer per asymmetric unit. A total of 
1720 residues were built in the asymmetric unit, 430 per subunit. The electron density for 
eight C-terminal residues was not observed, which suggests that the C-terminal in NAO 
is disordered. The model was refined to an overall Rcryst of 20.1 % and Rfree of 23.2 % to 
2.2 Å resolution (5% of the total reflections were not used in the refinements; (Brünger, 
Table 4.2 Phasing statistics for SeMet-ES* 
 peak (f”) remote inflection (f’) 





Resolution  (Å)  40 – 2.2 
 
40 – 2.5 
 
40 – 2.8 







Rcullis accentric (iso/ano) 
 
0 / 0.758 
 
0.978 / 0.840 
 
1.0 / 0.839 





Phasing power (iso/ano)  0 / 1.405 
 
0.361 / 0.974 
 
0.136 / 0.80 
FOMd 
 
0.13 (centric reflections) 7950 
0.32 (accentric reflections) 119500 
0.94 after solvent flattening in SOLOMON  
a Compiled from SHARP (de LaFortelle & Bricogne, 1997). 
b Rcullis = <phase-integrated lack of closure> / < | Fph - Fp | >, where Fph is the structure factor 
obtained from the inflection,  peak  data sets and Fp is obtained from the remote data set.  The 
isomorphous and anomalous differences are designated as iso and ano, respectively. 
c Phasing power = < [ | Fh(calc) | / phase-integrated lack of closure ] >, where Fh(calc) is the calculated 
structure factor for 52 Se atoms. 
d Figure of merit statistics describe a confidence level for the calculated centroid phases. 
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1992). The general model quality was judged form the estimated standard uncertainty 
values also known as diffraction precision index, calculated using REFMAC5  
(Cruickshank, 1999) (Table 4.3) and temperature factor plots (Figure 4.2). For detailed 
refinement statistics see (Table 4.4) The plots of the backbone torsion angles Φ, Ψ 
(Ramakrishanan & Ramachandran, 1965) for all the subunits of the homotetramer was 
calculated using PROCHECK analysis (Laskowski et al., 1993). All the residues lie 
either in the most or additionally allowed region except for Thr 90 from each subunit 
(Figure 4.1).  
 
 
 Table 4.3 Diffraction precision index (DPI) calculated based on Rcryst, Rfree and 
molecular likelihood value criteria. 
REFMAC DPI (Rcryst)a 
 
0.22 Å 
REFMAC DPI (Rfree)b 
 
0.18 Å 
REFMAC MLc                   0.12 Å 
a DPI(Rcryst) is given by (Ni/p)1/2C-1/3 Rcryst Dmin 
b DPI(Rfree) is represented by (Ni/nobs)1/2C-1/3 Rfree Dmin 
where Ni = number of atoms, corrected for scattering power; P = (number of observations – 
number of refined parameters); C = completeness of data at resolution Dmin; Dmin = 
resolution of data used in refinements; nobs = number of reflections used for refinement, not 
including the reflections used in calculating Rfree. 







Table 4.4 Refinement statistics for ES* 
Number protein residues 1720 
Number water molecules 694 
Resolution range (Å) 40 -2.2 
Number of reflections 130649 
Rcryst (%)a 20.16 
Rfree (%) 23.22 
Ramachandran Statistics  
Most favored 91.8% 
Additional allowed 7.7% 
Generously allowed 0.2% 
Disallowed 0.3% 




Ligand 52.65 (c atoms); 75.7 (nitro group) (100 % occupancy) (46.4 c atoms);  66.2( nitro group) (80 % occupancy) 
R.m.s.d. from ideal geometry  
Bond lengths (Å) 0.006 
Bond angles (o) 1.1 
a Rcryst is calculated as {Σh,k,l  | (|Fobs| - |Fcalc| ) | } / (Σh,k,l  |Fobs|); Rfree was calculated using 5% 









Figure 4.1 Ramachandran analysis for ES* homotetramer. The analysis was done 
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Residue number  
Figure 4.2 Variation in average temperature factor values along the polypeptide 
chain of ES*. The average B factor for each residue was calculated for all the chains 
in the ES*form of NAO. The calculations were done using CNS v.1.1. 
 
 
4.4 Data Collection Statistics for Oxidized NAO (form I, II and III)  
NAO has been crystallized in three crystal forms as described in the experimental 
section.  In each case the crystals were bright yellow suggesting the presence of oxidized 
FAD in the active site.  Each crystal form diffracts X-rays to at least 3.2 Å resolution and 
the data collection statistics are presented in (Table 4.5, 4.6). Crystal form I is remarkable 
because the trigonal space group has a 485 Å unit cell edge along c and typically display 
relatively low mosaic spread.  However, the unit cell parameters pushed the limits of the 
data collection facilities available at several synchrotron X-ray facilities.  Before a 
complete data set to 2.07 Å resolution was collected at BIOCARS (14-BMC) several 
attempts to collect a complete data set were unsuccessful (Table 4.6). Solvent content and 
Matthews coefficient analysis (Kantardjieff & Bernhard, 2003) suggested 1.5 NAO 













conditions yielded crystals in different space group (form II). Analysis of X-ray 
diffraction data revealed that a different space group and unit cell parameters for the 
NAO crystals in form II.  The solvent content and Matthews coefficient analysis 
(Matthews, 1968) suggested that there were two NAO homotetramers in the asymmetric 
unit (Table 4.5). 
 
Crystal form III grew with SeMet enriched NAO and conditions that included 
DTT, but otherwise typically yielded crystal form 1. The resulting space group was 
trigonal and systematic absences suggested either P31 or P32, but the c unit cell edge was 
significantly shorter (Table 4.5). The solvent content and Matthews coefficient analysis 
(Matthews, 1968) suggested that there were two NAO homotetramers in the asymmetric 
unit (Table 4.5) and a higher solvent content. Despite the presence of arsenic in the 
sodium cacodylate buffer system, a three wavelength MAD was successfully collected. 
Although preliminary analysis of the MAD data revealed good phasing statistics, the 
MAD data was not used for final structure solution of Eox. Significant computational 
cycles in the lab were used for locating 52 selenium sites in the MAD data set collected 
from SeMet-ES* crystals. Since ES* crystal structure was solved before 78 selenium 
sites could be located in the MAD data sets collected for form III, the three dimensional 
structure of oxidized NAO was solved by using molecular replacement methods.  
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Table 4.5 Data collection statistics for oxidized NAO (Form II and III) 






X-ray Source SER-CAT SER-CAT SER-CAT SER-CAT 
Beamline 22-ID 22-ID 22-ID 22-ID 





Detector marccd 165 marccd 225 marccd 225 marccd 225 
Resolution Range 
(Å) a 
35 – 3.2 
 
(3.4 – 3.2) 
50 – 2.8 
 
(2.9 – 2.8) 
50 – 2.8 
 
(2.9 – 2.8) 
50 – 2.8 
 
(2.9 – 2.8) 
Mosaic Spread  (°) ~ 0.6 ~ 0.3 ~ 0.3 ~ 0.3 
Space group P212121 P31 or P32 P31 or P32 P31 or P32 
Unit Cell  (Å), a 147.3 108.9 108.8 109.0 
b 153.5 108.9 108.8 109.0 
c 169.5 342.5 343.2 342.3 
VM (A3/Da) 2.5 3.0 3.0 3.0 
Solvent Content (%) 50 59 59 59 
Enzyme (α) / Asym. 
Unit 8 8 8 8 
Total Reflections 239001 767349 787263 690400 
Unique Reflections 55534 111892 111132 111156 
Multiplicity a 4.3 (2.7) 6.9 (5.2) 7.1 (6.4) 6.2 (4.5) 
Completeness (%) a 92.6 (92.6) 99.9 (99.6) 99.9 (99.8) 99.9 (99.8) 
Rsym a,b 0.073 (0.29) 0.126 (0.39) 0.126 (0.44) 0.147 (0.37) 
I/σ(I) a,c 7.8 (2) 11.4 (3.7) 11.8 (3.5) 11.5 (3.2) 
a Values for the highest resolution shell of data are given in parentheses.  b Rsym (I) 
gives the average agreement between the independently measured intensities such 
as ΣhΣi |Ii - I| / ΣhΣi I, where I is the mean intensity of the i observations of 
reflection h. c I/σ(I) is the root-mean-square value of the intensity measurements 
divided by their estimated standard deviation. 
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Table 4.6 Data collection statistics for oxidized NAO (Form I) 




Timeline Aug. 2002 Feb. 2003 March 2003 Aug. 2003 
X-ray Source SER-CAT SER-CAT NSLS BIOCARS 
Beamline 22 - ID 22 - ID X26C 14-BMC 
Wavelength (Å) 1.000 1.0332 1.0008 0.900 
Detector Mar165 Mar 165 Quantum 4R Quantum 4R 
Active area of 
Detector (mm) 
162 X 162  162 X 162  188 X 188  188 X 188  
Detector Distance 300 400 400 400 
Resolution Range (Å) a 30 – 4.0 
 
(3.85-4.0) 
30 – 2.25 
 
(2.15 – 2.25) 
50 - 2.5 
 
(2.6 - 2.5) 
50 - 2.07 
 
(2.15 -2.07) 
Mosaic Spread  (°) 0.38 0.32 0.4 0.36 
Space group P3221 P3221 P3221 P3221 
Unit Cell  (Å), a 103.72 103.14 103.4 103.82 
b 103.72 103.14 103.4 103.82 
c 487.45 484.09 485.1 485.4 
VM (A3/Da) 2.6 2.6 2.6 2.6 
Solvent Content (%) 53 53 53 53 
Enzyme (α) / Asym. 
Unit 
6 6 6 6 
Total Reflections 81400 200379 265114 570374 
Unique Reflections 38584 169489 199169 371128 
Multiplicity a 2.1(2.0) 1.2 (1.0) 1.3 (1.0) 1.53 (1.0) 
Completeness (%) a 78 (77.5) 65.1 (25.4)  89.1 (77.1) 93.5 (80.0) 
Rsym (%) a,b 10.6 (14.0) (30.4) 9.3 (18) 13.9 (30.1) 
I/σ(I) a,c 6.0 (4.8) 11.2 (4.2) 14.3 (8.3) 12.6 (3.0) 
a Values for the highest resolution shell of data are given in parentheses.  b Rsym (I) gives 
the average agreement between the independently measured intensities such as ΣhΣi |Ii - I| 
/ ΣhΣi I, where I is the mean intensity of the i observations of reflection h. c I/σ(I) is the 
root-mean-square value of the intensity measurements divided by their estimated standard 
deviation. 
 90
4.5 The Quality of Oxidized NAO Crystal Structure 
The final model consists of 1.5 homotetramers per asymmetric unit. A total of 
2580 residues were built in the asymmetric unit, 430 per subunit. The electron density for 
eight C-terminal residues was not observed, which suggests that the C-terminal in NAO 
is disordered. The model was refined to an overall Rcryst of 18.8 % and Rfree of 22.5 % to 
2.07 Å resolution (5% of the total reflections were not used in the refinements; (Brünger, 
1992). The general model quality was judged form the estimated standard uncertainty 
values also known as diffraction precision index, calculated using REFMAC5  
(Cruickshank, 1999) (Table 4.7) and the temperature factor plot (Figure 4.4). For detailed 
refinement statistics see (Table 4.8). The plots of the backbone torsion angles Φ, Ψ 
(Ramakrishanan & Ramachandran, 1965) for all the subunits of the homotetramer were 
calculated using PROCHECK analysis (Laskowski et al., 1993). All the residues lie 
either in the most or additionally allowed region except for Thr 90 from each subunit 












Table 4.7 Diffraction precision index (DPI) calculated based on Rcryst, Rfree and 
molecular likelihood value criteria. 
 








REFMAC MLc                  
 
0.11 Å 
a DPI(Rcryst) is given by (Ni/p)1/2C-1/3 Rcryst Dmin 
b DPI(Rfree) is represented by (Ni/nobs)1/2C-1/3 Rfree Dmin 
where Ni = number of atoms, corrected for scattering power; P = (number of observations – 
number of refined parameters); C = completeness of data at resolution Dmin; Dmin = 
resolution of data used in refinements; nobs = number of reflections used for refinement, not 
including the reflections used in calculating Rfree. 













Table 4.8 Refinement statistics for oxidized form of NAO 
Number protein residues  2580 
Number water molecules 1136 
Resolution range (Å) 50 – 2.07 
Number of reflections 171484 
Rcryst (%)a 18.76 
Rfree (%) 22.51 
Ramachandran Statistics  
Most favored 93.3% 
Additional allowed 6.2% 
Generously allowed 0.3% 
Disallowed 0.3% 




Ligand (Spermine) - 4 molecules  46.31 
Ligand (Glycerol) - 14 molecules 50.23 
Ligand (PEG 4000) - 2 molecules 51.45 
R.m.s.d. from ideal geometry  
Bond lengths (Å) 0.013 
Bond angles (o) 1.4 
a Rcryst is calculated as {Σh,k,l  | (|Fobs| - |Fcalc| ) | } / (Σh,k,l  |Fobs|); Rfree was calculated using 5% 








Figure 4.3 Ramachandran analysis for oxidized form of NAO. The analysis was 










0 40 80 120 160 200 240 280 320 360 400 440
Residue number  
Figure 4.4 Variation in the average temperature factor values along the polypeptide 
chain. The average B factor for each residue was calculated for all the chains in the 
oxidized form of NAO. The calculations were done using CNS v.1.1. 
 
 
4.6 Structural Comparison of Different Reaction States of NAO 
The plot of average solvent accessible surface area along the polypeptide chain in 
all the three different forms of NAO is very similar (Figure 4.5). The continuous regions 
of low solvent accessibility occur between 73-105, 277-293, 327-340, 352-380 and 394-
414. Most of the residues in these regions correspond to the N5 access substrate access 
channel and the active site loop. The highest solvent accessible surface area (17 – 20 Å2) 
is observed for residues numbers 36, 64, 157, 222, 344, 420 and 431.  
 
The structural overlap between ES* and oxidized NAO homotetramer gave a low 
r.m.s.d. of 0.3 Å. The r.m.s deviation plots along the polypeptide chain between the 













b, c). The large shifts in the side chain conformations are correlated with the high solvent 
accessible surface areas, which is expected since solvent exposed side chain can adopt 
different conformations. The r.m.s deviations are more meaningful for the residues that 
have low solvent accessibility. The residues that are solvent exposed are more likely to 
have different side chain conformations in comparison to the residues that are not 
involved in crystal packing and are buried inside the protein. For these reasons, a 1.26 Å 
shift in Asp402 side chain can be stated with greater confidence in comparison to a 4 Å 





































Figure 4.5 Average solvent accessible surface area of the residues in different 
reaction states of NAO. The uninhibited state of NAO, Eox (chain A) is shown in 
green; The inhibited state of NAO, EI (chain B) is shown in magenta; The N5-FAD 






Figure 4.6 a) The mean positional variation of the side chain (magenta) and the 
main chain (violet) residues of ES* (chain B) versus the residues in the inhibited 
state of NAO, EI (chain B); b) The mean positional variation of the side chain 
(magenta) and the main chain (violet) residues of ES* (chain A) versus the residues 
in the uninhibited state of NAO, Eox (chain A); c) The mean positional variation of 
the side chain (magenta) and the main chain (violet) residues of EI (chain B) versus 
the residues in the uninhibited state of NAO, Eox (chain A). Individual chains were 
superimposed using SUPERPOSE routine in CCP4  (Krissinel & Henrick, 2004). 
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5 CRYSTAL STRUCTURES OF NITROALKANE 
OXIDASE 
 
††Nitroalkane oxidase (NAO) from Fusarium oxysporum catalyzes the oxidation 
of the neutral nitroalkanes to the corresponding aldehydes or ketones with production of 
H2O2 and nitrite. The flavoenzyme is a new member of the acyl-CoA dehydrogenase 
(ACAD) family, but it does not react with acyl-CoA substrates. We present the 2.2 Å 
resolution crystal structure of NAO trapped during turnover of nitroethane as a covalent 
N5-FAD adduct (ES*). The homotetrameric structure of ES* was solved by MAD 
phasing with 52 Se-Met sites in an orthorhombic space group. The electron density for 
the N5-(2-nitrobutly)-1,5-dihydro-FAD covalent intermediate is clearly resolved. The 
structure of ES* was used to solve the crystal structure of oxidized NAO (Eox) at 2.07 Å 
resolution. The c axis of trigonal space group for Eox is 485 Å and there are 1½ 
holoenzymes in the asymmetric unit. Four of the active sites contain spermine (EI), a 
weak competitive inhibitor and two are empty (Eox). The structures of Eox, EI and ES* 
reveal a hydrophobic channel that extends from the exterior of the protein to the re-face 
of the FAD which terminates at the N5-FAD position. The structures show that Asp402 is 
located at the end of the substrate access channel. Moreover, the residue is in the correct 
position to serve as the active site base, where it is proposed to abstract the α-proton from 
neutral nitroalkane substrates. The protein fold for NAO and various members of the 
ACAD family overlay with root mean square deviations between 1.7 to 3.1 Å. The 
homologous region typically spans more than 325 residues and includes Glu376, which is 
                                                 
†† This chapter has been reformatted from the NAO manuscript prepared for Nat. Str. Biol. (Nagpal et al., 
2005) 
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the active site base in the prototypical member of the ACAD family. However, NAO and 
the ACADs exhibit differences in hydrogen the bonding between the respective active 
site base, substrate molecules and the FAD. These likely differentiate NAO from the 
homologs and consequently, are proposed to result in the unique reaction mechanism of 
NAO.  
 
5.1 Overview of the NAO Structures 
The trapped intermediate of NAO, ES*, crystallized at 4 °C in space group 
P212121 with one homotetramer per asymmetric unit (VM 3.4; 63% solvent). The ES* 
structure has 222 local symmetry relating the four subunits to each other (Figure 5.1). 
The tetrahedron-shaped holoenzyme is approximately 100 Å wide (measured between Cα 
of Gly158a and Gly158b‡‡; and approximately 80 Å tall (measured between Cα of Thr34b 
and Thr34c). The oxidized form of NAO, Eox, crystallized in space group P3221 from 
slightly different conditions that include spermine tetrahydrochloride (Nagpal et al., 
2004). The volume of the trigonal unit cell is greater than 4,570,000 Å3 and contains six 
monomers per asymmetric unit (VM 2.6; 53% solvent). These are arranged as one 
complete homotetramer and one-half of another holoenzyme. However, the additional 




                                                 
‡‡ Residue naming convention – residue number followed by chain ID 
 99
 
Figure 5.1 A divergent stereo view of the NAO homotetramer in the ES structure.  
Each subunit is depicted as a differently colored Cα ribbon trace and the FAD 
covalent adducts are shown in CPK atoms within each subunit.  An A:B dimer can 
be considered as consisting of a purple and yellow pair of subunits. 
 
 
Biochemical studies (Gadda & Fitzpatrick, 1998) and our crystal structures 
suggest that NAO is a homotetramer comprised of a dimer of dimers. Subunit A forms 
extensive interfaces with subunits B and C. In contrast, only the side chains of Gln314a, 
Ser315a and Asp318a form hydrogen bonds across a two-fold axis with residues from 
subunit D. The buried surface area at the A:C dimer interface is slightly greater (~ 5270 
Å2; 16.5% of the total solvent accessible surface area for a subunit) than that between the 
A:B dimer (~ 4560 Å2; 14% of the total). The A:C dimer and B:D dimer are stabilized by 
several types of interactions. For example, residues from subunit A along helix K (Figure 
5.2, 5.3) and the C-terminal region form hydrogen bonds with residues from helix H and 
G of the subunit C. In addition, four salt bridges also stabilize the A:C interface: 
Lys324a-Glu353c, Arg410a-Asp318c, Arg410a-Asp322c and Arg411a-Asp318c. The 
active site within subunit A contains residues from chain A as well as few of the residues 
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from subunit B (discussed further below). Therefore, the homotetramer can be described 
as an A:B dimer with a C:D dimer interface.   
 
The secondary and tertiary structures of each NAO subunit is comprised of two α-
helical domains (approximately residues 1-125 and 260-438) and a central β-sheet 
domain (approximately residues 125-260) (Figure 5.2, 5.3). The α-helical domains form 
the core of the holoenzyme and the β-sheet domains are located on the exterior, 
approximately at the points of the tetrahedron shape. Each subunit in the two asymmetric 
units of the oxidized NAO and the ES* structures have very similar structures (r.m.s.d. of 
all Cα atoms ~ 0.25 Å), despite the fact that non-crystallographic symmetry was not 








Figure 5.2 A ribbon drawing of one NAO subunit showing the β sheet domain (blue) 
sandwiched between the N-terminal α domain (green) and the C-terminal α domain 
(gold). The FAD is shown as CPK atoms with the N5 substrate access channel and 






Figure 5.3 Amino acid sequence and 2° structural and alignments of NAO and several homologs. The 
residue numbering for NAO is on the top and for the homologs on the right hand side. Naming of the 
2° structural elements are for the NAO structure. The 2° structural assignments are shown in the 
same order as the 1° sequences. MCAD, medium chain acyl-CoA dehydrogenase (3mde); SCAD, 
short chain isovaleryl acyl-CoA dehydrogenase (1ivh); ACO-II, acyl-CoA oxidase II from rat liver 
peroxisomes (1is2); ACO-I, acyl-CoA oxidase I from Arabidopsis thaliana (1w07); Acyl-ACP, acyl-
ACP dehydrogenase from the FK520 polyketide biosynthetic pathway (1r2j). The active site residues 
lining the N5 substrate access channel in NAO are indicated with filled triangles. Residues that are 
100% conserved are highlighted in red and those present in at least 4/6 are in yellow. The active site 
bases are all donated from the J-K loop, except where noted (shown in green). The conserved lysine 
that stabilizes the J-K loop is from α-helix I, except where noted (shown in blue). The ACO-II and 
ACO-I amino acid sequences are truncated to 500 and 497 residues respectively. The alignment was 
prepared by using CLUSTALW and ALSCRIPT (Higgins et al., 1994; Barton, 1993). 
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5.2 Architecture of the Active Site 
Each NAO subunit binds one FAD non-covalently in an extended conformation 
(Figure 5.2, 5.4). The isoalloxazine ring is located between the β sheet domain on the si-
face and on the re-face by α-helices E, G, F1 and the JK loop. The FAD in subunit A also 
packs against subunit B in several regions. For example, the turn between Ala376b to 
Met379b, the only counter ion to the FAD phosphate moieties is Arg304b, and His313b 
π-stacks with the adenine ring of the FAD. The adenine moiety of the FAD extends to the 
dimer-dimer interface, where it hydrogen bonds with the side chains of Gln314 of the 




Figure 5.4 A divergent stereo view of the solvent accessible surfaces around the FAD 
in subunit A of the Eox active site. The FAD is shown as CPK atoms with carbon, 
nitrogen, oxygen and phosphorus atoms colored green, blue, red and magenta, 
respectively. The active site base, Asp402, as well as Phe401 and Phe273 are shown 
as sticks with carbon atoms colored yellow. The surfaces are colored according to 
the atoms that form the boarder, with gray surface in subunit A and purple surfaces 
from subunit B. The N5 channel extends from the bottom-right, to the right of  α 
helix G and terminates under the Phe401-Asp402 residues. The N1 channel extends 





The crystal structure of oxidized NAO contains six subunits in the asymmetric 
unit. The electron density maps indicate that four of the active sites contain spermine 
(EI), a weak competitive inhibitor (Ki ~200 mM at pH 8) and two are empty (Eox) (Figure 
5.5 a,b). The electron density for the covalent adduct in the ES* structure is clearly 
resolved and suggests full occupancy (Figure 5.5 c). Our crystal structures correlate well 
with previous biochemical studies and confirm the presence of Cys397, Tyr398 and 
Asp402 (Gadda et al., 2000b; Gadda et al., 2000a; Valley & Fitzpatrick, 2003b) in the 
active site. The active site Tyr398 was identified by tetranitromethane modification 
(Gadda et al., 2000) and our structures show that it is located on the re-face of the FAD 
(Figure 5.6). Cys397 was also identified by chemical modification experiments (Gadda et 




Figure 5.5 Examples of the electron density at the active site in the two structures of 
NAO.  a) empty active site of oxidized NAO (Eox) b) active site containing spermine 
inhibitor (EI). c) The covalent adduct trapped during turnover of nitroethane (ES*) 
and the corresponding chemical formula (Gadda et al., 1997) are also shown. The 
2mFo - DFc electron density maps are contoured at 1σ and calculated to 2.07 




Each of the structures reveals several solvent accessible or excluded cavities 
associated with the FAD (Figure 5.4). However, only about 16 Å2 (4.5%) of the 
isoalloxazine ring surface area in Eox is accessible to solvent (Figure 5.4). The largest 
solvent accessible channel extends from the exterior of the protein and terminates at the 
N1 atom, the ribityl portion of the FAD, and residue Phe273. We define this as the N1 
channel. It is lined with several charged and hydrophilic residues, and contains several 
solvent molecules. The second channel also extends from the protein exterior and 
terminates at the FAD N5 atom and residues Phe401 and Asp402. We define this as the 
N5 channel and suggest that aliphatic substrates may enter the NAO active site through 
this channel. The 26 Å long channel is funnel-shaped and passes through the interface 
formed by the N-terminal and C-terminal α-helical domains. In the middle, an 
approximately 9 Å diameter constriction is formed by residues Val95 and Val280. The 
interior walls of the channel are bordered exclusively with the hydrophobic residues from 
α-helices C1, D, E, G and J-K loop. The total solvent accessible volume of the N5 
channel is approximately 345 Å3. The spermine molecules in the EI active sites occupy 
approximately 72% of that volume and exclude the FAD C4a and N5 atoms from solvent. 
This correlates with the preference for the hydrophobic nitroalkane substrates with each 
methylene group contributing ~2.6 kcal mol-1 of binding energy (Gadda & Fitzpatrick, 
1999). The re-face of the isoalloxazine ring in the covalent adduct of ES* is similarly 
excluded from solvent, but one water molecule is hydrogen bonded to the O4 atom of the 
FAD in each structure. The exterior opening of the N5 channel is approximately 15 Å 
wide and is surrounded by the hydrophobic residues (Ile64, Pro65, Leu66, Ile105, 
Leu106, and Trp348) and charged residues (Glu71, Ser72, Thr271, Glu342, Glu344, and 
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Lys351). The presence of three negatively charged residues on the periphery of the 
substrate channel suggests, in part, a structural basis for NAO substrate discrimination 
against nitronate substrates. A third, solvent-excluded cavity is located parallel to the 
FAD si-face. It contains five ordered solvent molecules, but only the dimethylbenzene 
portion of the isoalloxazine ring boarders the dumbbell-shaped cavity. The rest of the 
cavity boundary is comprised of the side chains of several residues as well as portions of 
the protein backbone (Phe43, Ile92, Thr93, Trp169, Ser171, Asn172, Glu231, Pro232, 
Leu234, Thr240 and Gly242). The cavity is very close to the A:B subunit interface and 
only excluded from bulk solvent by the side chains of Leu168, Trp169 and Pro232. 
 
The structures of Eox, EI and ES* clearly show the location of Asp402, the 
essential active site base identified by several types of experiments (Gadda et al., 2000b; 
Gadda et al., 2000a; Valley & Fitzpatrick, 2003b). It is poised directly above the re-face 
of the FAD and the side chain also interacts with the guanidinio group of Arg409 via 
electrostatics and hydrogen bonds. Asp402 is located within a loop between the J and K 
α-helices (residues Pro399 to Asn405). As a result, the carbonyl oxygen atoms of 
Tyr398, Phe401, Gly403 and side chain oxygen of Asn405 are forced into close 
proximity to each other. The resulting negative electrostatic field is further enhanced by 
the C-terminal end of the J α-helix. These influences are compensated for by the 
positively charged Nε atoms of Lys359 via hydrogen bonding and electrostatic 
interactions (Figure 5.6). Consequently, the J-K loop is properly orientated such that 




Figure 5.6 A view showing active site residues on JK loop. Lysine 359 forms 
electrostatic interactions with the backbone and side chain oxygens of the active site 
loop residues. Lysine is conserved throughout the ACAD family except for iso-
valeryl acyl CoA dehydrogenase  (ICAD) in which arginine 387 plays the same role. 
 
 
The position of the FAD isoalloxazine ring is stabilized through several hydrogen 
bonds with the pyrimidine ring (Figure 5.7). This includes backbone atoms from Lue131, 
His133 and Ser134. In addition, the hydroxyl groups of Ser134 and Ser171 hydrogen 
bond with the FAD N1 and N5 atoms, respectively. Hydrophobic interactions with the 
dimethylbenzene ring are provided by Ile92, Trp169, Leu234, Phe401, and Met379b. 
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Moreover, there is a nearly perpendicular relationship between the aromatic ring of 
Phe401 and the FAD dimethylbenzene ring (Figure 5.4, 5.5). Such a T-shaped 
configuration is known to stabilize benzene and substituted benzene dimers by 
interactions between the electronegative π-orbitals and the electropositive edge of the 
aromatic ring (Sinnokrot & Sherrill, 2004; Pellett et al., 2001) The electron density for 
the isoalloxazine rings in Eox and EI indicate that they are distorted from planarity by 
approximately 15°, presumably by the combined influences of these interactions (Figure 
5.8, Table 5.1). The piperizine ring in the ES* structure is also puckered at the N5 atom 
and consequently, yields a larger distortion (~21°). These features are consistent with a 
reduced FAD in the N5 adduct. Similar distortions of the isoalloxazine ring systems have 
also been observed recently for N5 and C4a covalent adducts of mono-amine and 
polyamine oxidases (Binda et al., 2003; Binda et al., 2001), which have structures that 
are otherwise completely unrelated to NAO. In each case, the deviation from planarity is 
principally along the N5-N10 axis, which bisects the essentially planar dimethylbenzene 









Figure 5.7 Schematic representation of the residues interacting with FAD in the active site 
of Eox. The figure was prepared with LIGPLOT (Wallace et al., 1995) 
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Figure 5.8 The isoalloxazine rings display deviations from planarity in both Eox and 
ES* structures. The angle shown is the average of all the active sites in each 
asymmetric unit and depicts the C4-N5-C6 angle. 
 
 
Table 5.1 Angles between the dimethylbenzene and pyrimidine rings of the FADs in 
the NAO structures a 
 Eox ES* 
C4-N5-C6 (°) 164.4 ± 1.1 158.8 ± 1.0 
N1-N10-C9 (°) 164.9 ± 1.5 166.9 ± 0.7 
Average (°) 164.6 ± 1.3 162.5 ± 4.8 
a The values shown are for the average of the six or four independently refined active 





5.3 Comparisons of the Eox, EI and ES* Active Sites 
The overall polypeptide fold is very similar in the two structures of NAO (r.m.s.d. 
for Cα atoms of approximately 0.27 Å; 0.34 Å for 6876 backbone atoms in 429 residues 
per subunit). The structural overlay of homotetramers of oxidized NAO and the ES* 
complex reveals small shifts of the residues in the J-K loop and in several residues 
bordering the si-face. However, perhaps the functionally most important of these shifts 
are illustrated in (Figure 5.9, 5.10). For example, in the resting state of the enzyme 
(subunit A, Eox), Asp402 forms many hydrogen bonds with several other residues and a 
solvent atom (Wat297).  Most of these interactions are maintained in the EI and ES* 
complexes, but the three solvent molecules are displaced. Moreover, as illustrated, in 
subunit A of ES*, the orientation of Ser276 and Asp402 are both altered compared to the 
Eox active site (Figure 5.9). Indeed, the side chain of Asp402 in subunit A of ES* has 
rotated almost 90° to form hydrogen bonds with the nitro group of the adduct and with 
the guanidinio group of Arg409. In addition, Ser276 has also rotated into an alternative 
orientation (Figure 5.11). In contrast, a comparison of subunit B from oxidized NAO and 
the ES* complex illustrates yet another set of conformations (Figure 5.10, 5.12). In this 
EI subunit, the spermine molecule has displaced the three solvent molecules. The protons 
from the terminal cationic nitrogen likely form hydrogen bonds with the FAD 2’ OH 
ribityl chain and thus stabilize the binding of the inhibitor directly above the FAD re-
face. However, the side chains of both Asp402 and Ser276 are in similar orientations 
within these subunits. Therefore, Asp402 has at least two possible orientations, which are 




Figure 5.9 A divergent stereo view comparing Eox (subunit A) with ES* (subunit A).  
Bonds for the Eox structure are in yellow, whereas those for the ES* are in grey; 
hydrogen bonds are shown with dashed green lines. Three solvent molecules (cyan) 
in the Eox structure are not present in the ES* complex. Note the alternative 
orientations and hydrogen bonding patterns associated with Asp402 and Ser276 for 




Figure 5.10 A divergent stereo view comparing EI (subunit B) with ES* (subunit B). 
The bonds for the EI complex are shown in yellow. Note that Asp402 and Ser276 







Figure 5.11 A divergent stereo view of ES* (subunit A) with the active site residues. 
The 2mFo - DFc  maps shown in the figure are contoured at 1 σ level. Note the side 




Figure 5.12 A divergent stereo view of ES* (subunit B) with the active site residues. 
The 2mFo - DFc  maps shown in the figure are contoured at 1 σ level. Note the side 






Previous results have shown that the modified FAD adduct isolated from NAO is 
not stable in solution at high pH and converts rapidly to oxidized flavin (Gadda et al., 
1997). In contrast, our structural analysis of ES* suggests that stability of the adduct in 
the protein is likely the result of several factors (Figure 5.13) As suggested in the NAO 
reaction scheme (Figure 5.14), the decay of the adduct via step 9 may be related to the 
stability of the delocalized negative charge on N1 and O2 atoms of the pyrimidine ring. 
Our structures indicate that both the O2 and the N1 atoms form stable hydrogen bond 
interactions with two main chain amide protons and the hydroxyl group of Ser134, 
respectively (Figure 5.13). Some of the active sites of the ES* show that the nitro group 
of the adduct interacts with the side chain of Asp402, which is also coupled with Arg409. 
These interactions may reduce the ability to generate the NO2- leaving group as dictated 
by step 9 of scheme 1. In addition, the lack of O2 reactivity of the reduced FAD-N5 
adduct can be rationalized in part, by steric effects of the protein backbone on the si- face 
of the flavin (Figure 5.15). For example, the N5-(2-nitrobutyl) moiety forms on the re-
face of the flavin and residues Trp169, Pro170 and Ser171 all pack the FAD si-face. 
Although there is a solvent excluded cavity on the si-face under the dimethylbenzene 
ring, access to C4a is not possible without a conformational change. Therefore upon 





Figure 5.13 Divergent stereo image showing the environment around, and various 
hydrogen bonds stabilizing, the N5-(2-nitrobutyl)-1,5-dihydro-FAD moiety. Leu99, 
Phe273 although within 5 Å of nitrobutyl moiety have been removed to have a clear 
view. Residues not labeled in figure are: Ile92, Val95, Ala96, Leu131, Trp169, 




































































































































Figure 5.14 The proposed NAO reaction mechanism with nitroethane as substrate (Gadda 
& Fitzpatrick, 2000e) 
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Figure 5.15 Hypothetical FAD-C4a:H2O2 complexes modeled with MOPAC 
simulations in CHEM3D using either a re-face complex (left, normal isoalloxazine 
ring system) or a si-face complex (right, N5-blocked system). Each model was 
overlapped with the isoalloxazine ring in either the Eox or the ES* complex, 
respectively. Note that the re-face complex is not sterically hindered and that 
Arg409-Asp402 residue appear to be positioned to donate one or more protons in 
the oxidative half-reaction. In contrast, the si-face complex has several steric clashes 
and no proton donors nearby. 
 
 
5.4 Comparison to the ACAD Family Members 
The structural homologs of NAO include family members of the mitochondrial 
acyl-CoA dehydrogenases (ACAD) (Kim & Miura, 2004), acyl-CoA oxidase (ACO) I 
from Arabidopsis thaliana (Pedersen & Henriksen, 2005), ACO II from rat liver 
peroxisomes (Fitzpatrick et al., 2005), and the acyl-ACP dehydrogenase from polyketide 
biosynthetic pathways (Watanabe et al., 2003). Both ACADs and ACOs catalyze the 
oxidation of acyl-CoA thioesters to their corresponding trans-Δ2-enoyl-CoA. However, 
the reactions differ in the oxidative half-reactions. The ACAD family members transfer 
reducing equivalents to the electron transfer flavoprotein for use in the oxidative 
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phosphorylation cascades. In contrast, the ACOs are located in the peroxisome and use 
O2 in the oxidative half-reaction to yield H2O2. NAO shares more sequence similarity (41 
- 45%) with various ACAD family members and only 7 - 9% sequence similarity with the 
two ACOs. The regions of homology are not limited to particular domains and are spread 
throughout the entire primary sequence, with the exception of the C-terminal region of 
the ACOs (Figure 5.3). The overall structural similarity among the family members is 
also evident from the r.m.s. differences (Table 5.2) that range from 1.7 Å for the medium 
chain acyl-CoA dehydrogenase (MCAD) to 2.6 Å for the ACO-I (Figure 5.16). The Q 
scores range between 0.64 (MCADs) and 0.2 (ACOs) (Krissinel & Henrick, 2004). 
Despite these similarities, numerous molecular replacement trials failed to solve the 
structure of the ES* complex of NAO. 
 
 
Table 5.2 Similarity between NAO-ES* and selected homologous proteins 
Homolog Q-scorea R.M.S.D.  Number Cα 
MCADb 0.63 1.67 369 
ACO – Ic 0.22 2.59 328 
ACO – IId 0.21 3.11 331 
BSCADe 0.55 1.95 352 
Rat SCADf 0.57 2.01 355 
ICAD 0.57 1.90 359 
Acyl-ACPDh 0.48 2.15 327 
Glutaryl-CoADi 0.50 2.07 349 
a Q score is defined as Nalgn * Nalgn / (1+(RMSD/R0)2) * Nres1 * Nres2, where Nalgn is the 
length of alignment and Nres1 and Nres2 are the number of total residues in the NAO and 
the target PDB structure. Calculations were done using the Secondary Structure Matching 
server (Krissinel & Henrick, 2004). b Medium chain acyl-CoA dehydrogenase from PDB 
entry (3mde). c Acyl-CoA Oxidase isoforms I from PDB entry (1w07). d Acyl-CoA 
Oxidase II from PDB entry (1is2). e Bacterial acyl-CoA dehydrogenase from PDB entry 
(1buc). f  Short chain acyl-CoA dehydrogenase from PDB entry (1jqi). g Isovaleryl-CoA 
dehydrogenase from PDB entry (1ivh). h Acyl-carrier protein dehydrogenase from PDB 
entry (1r2j). i Glutaryl-CoA dehydrogenase decarboxylase from PDB code (1siq). 
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Figure 5.16 Crystal structures of nitroalkane oxidase, medium chain acyl-CoA 
dehydrogenase, and acyl-CoA oxidase displayed in similar orientations and scales. 
Shown are the Cα ribbon traces for: a) the α4 holoenzyme of NAO; b) one subunit 
of NAO with FAD shown with space filled, CPK colored atoms; c) the α4 
holoenzyme of pig liver mitochondrial medium-chain acyl-CoA dehydrogenase 
(from PDB code 3mde, (Kim, J.-J. P. et al., 1993)); d) one subunit of MCAD with 
FAD and with octanoyl-CoA in ball and stick format; e) the α2 holoenzyme of rat 
liver peroxisomal acyl-CoA oxidase-II holoenzyme (from PDB code 1is2, (Nakajima 
et al., 2002)); f) one subunit of ACO with FAD. 
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The structural, mechanistic, mutagenic and spectroscopic analysis of the medium 
chain ACAD (MCAD) provides exquisitely detailed proposals for the structural 
contributions of active site residues to catalysis (Ghisla & Thorpe, 2004; Kim & Miura, 
2004). For example, the structures of MCAD bound to transition-state analogs, substrates 
or products clearly show that the acyl-CoA moiety occupy the N1 channel adjacent to the 
ribityl portion of FAD (Kim, J. J. et al., 1993; Satoh et al., 2003) (Figure 5.17 c). In 
contrast, our structure of EI shows that spermine occupies the N5 channel on the opposite 
side of the FAD (Figure 5.17 a). Moreover, the substrates cannot bind productively to 
NAO via the N1 channel since it is interrupted by the side chains of Phe273, Leu408 and 
Arg415. NAO does not react with acyl-CoA substrates, perhaps because several 
important binding determinants in the N1 channel of the ACADs are missing in NAO. 
For example, several residues that form hydrogen bonds with acyl-CoA substrates in the 
N1 channel of MCAD are replaced by alanines in NAO (Figure 5.17 c, d). Similarly, 
substrates cannot access the MCAD active site via the analogous N5 channel because the 
entrance of the channel is blocked by the side chain of His65. Moreover, the N5 channel 
in MCAD is interrupted by the side chains of Thr255 and Thr102, which results in two 








Figure 5.17 a) The N5 substrate access channel in NAO along with the active site 
NAO residues, inhibitor spermine (green) and the FAD (orange) overlapped with 
the corresponding active site residues from MCAD transition state complex (PDB 
code, 1udy) (cyan).  
b) The N5 buried cavities in MCAD transition state complex (PDB code, 1udy) 
complex overlapped with corresponding active site residues and FAD from NAO EI 
complex. The MCAD and NAO residues are labeled and colored as in (a). The 
cavities in the MCAD are interrupted by Thr255 and blocked from the exterior by 
His65.  
c & d) MCAD residues lining the N1 channel (magenta) and the corresponding 
residues from NAO (green). The residues in N1 channel of NAO sterically block the 
access to active site FAD. The hydrogen bond donors and acceptors for the substrate 





Apart from the differences in the substrate access channel, the structural comparisons 
of NAO with ACADs also highlight the differences in the hydrogen bonding associated 
with the active site base, FAD and substrates. All these interactions are important 
determinants in guiding a particular reaction chemistry. The active site in NAO can be 
described as a two layer sandwich. In contrast, the ACADs, has three layers in the active 
site, the FAD, the substrate and the active site loop. Most of the hydrogen bonding 
interactions between isoalloxazine ring and the protein backbone are conserved in NAO 
and are similar to those of the ACADs (Figure 5.18). The hydrogen bond between 2’OH 
of the ribityl chain and the terminal nitrogen of spermine is also similar to the one 
observed between the carbonyl thioester of acyl-CoA substrate and 2’OH of the ribityl 
chain of FAD in ACADs. This particular hydrogen bond has been shown to lower the 
pKa of the acyl-CoA substrates in ACADs and is suggested to play a similar role in 
NAO. In NAO, 2’OH and 4’OH of ribityl chain of the FAD is hydrogen bonded to the 
amide nitrogen of active site base, Asp 402. The hydrogen bond interaction between Asp 
402 and 2’OH and 4’OH of the ribityl chain are unique to NAO and not present in other 
ACAD superfamily members. In addition to above mentioned hydrogen bonds, 4’OH of 
the ribityl chain in NAO also forms hydrogen bonds with other residues on the active site 
loop (amide nitrogen of Gly403 and carbonyl oxygen of Leu400). These hydrogen bonds 
are missing in MCADs.  
 
In MCAD, all the oxygens of the FAD phosphates face towards si-face leaving more 
room for the acyl-CoA substrates on the re-face. For example, in MCAD, the two 
oxygens of the first phosphate hydrogen bond with NH1 of Arg281 and amide nitrogen of 
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Gly353 from the adjacent subunit whereas in NAO the oxygens from the first phosphate 
face towards re-face and form hydrogen bond with amide N of Gly404 from the same 
subunit and Met379 from the other subunit. Both in NAO and MCAD the oxygens from 
the second phosphate face the si-face of FAD and are stabilized through various 
hydrogen bonds. In NAO, one of the oxygens from the second phosphate hydrogen bonds 
with the NH1 of Arg304 from the other subunit, which suggests that dimer formation is 
not only structurally important in NAO but is also critical part of FAD environment. 
 
The Arg409 forms an ionic and hydrogen bond interaction with Asp402 in our 
NAO structures. This feature is unique to NAO compared to the other homologs. 
Interestingly, the guanidine group of Arg256 in MCAD occupies an approximately 
analogous position. However, the group does not from a hydrogen bond to the analogous 
active site base, Glu376, but rather packs the hydrophobic portion against the acidic side 
chain. Thus a positive charge is approximately conserved in the three dimensional space, 
but is donated from residues on opposite sides of the active site cavity. In conclusion, the 
substrate specificity of NAO can be attributed to the differences in substrate access 
channel, FAD environment and hydrogen bonding interactions with the active site base. 
 
The solvent accessible surface area (SASA) of N5 (~6.0 Å2) in Eox is comparable 
to ACOs (~5.5 Å2), but far higher than the observed values for MCAD (2.4 Å2). In 
contrast, the SASA value for C4a is lowest for NAO (1.2 Å2) in comparison to values 
reported for other homologs (ACOs -2.6 Å2 and MCAD – 1.9 Å2). The substrate binding 
and adduct formation in NAO completely shield C4a and N5 from solvent, as evident 
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from zero values of SAS. This observation suggests that products of NAO reaction cycle 
likely dissociate in order to make the C4a accessible to O2. This is in contrast to acyl-
CoA products, which bind tightly in the active site of ACADs and thus prevent the entry 





Figure 5.18 Active site comparison of the EI complex of NAO and the MCAD:acyl-CoA-
TSA complex (PDB code 1udy) 
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Another striking feature of the ACAD family members is the presence of a 
structurally conserved Lys, which corresponds to residue 359 in NAO. The charged Nε 
atom of Lys is surrounded by four oxygen atoms similar to the K+ selectivity filter in the 
K+ channel (Figure 5.6) (Doyle et al., 1998). In all the ACAD superfamily members, the 
site appears to function to interrupt the “J” α-helix and promote the distinct turn in the 
peptide backbone trace. This consequently places the active site base Asp402 and the 
FAD in proper position for reaction (Figure 5.18,). The Lys is not conserved in the 
primary amino acid sequence of iso(3)valeryl-CoA dehydrogenase (ICAD) (Figure 5.6) 
(Tiffany et al., 1997) but a structurally analogous Arg381 is present. Although the active 
site base, Glu254 in ICAD resides on α helix “G” rather than on the J-K loop (Figure 
5.3), a structurally conserved positive charge is still required for twisting the helix K in 
the active site. A helical twist of 40o between helix J and helix K in ICADs is very similar 
to the one observed in other ACADs (helical twist 45o). The turning of K α helix is 
critical in ACADs to maintain the active site architecture. It allows the acyl-CoA 
substrates, which bind in the N1 substrate channel to access the active site FAD. 
Although, NAO substrates bind via N5 substrate access channel, a conserved helical twist 
of 40o between helix J and helix K is still observed and is suggested to be important for 









Nitroalkane oxidase (NAO), a flavoenzyme, from Fusarium oxysporum catalyzes 
the oxidation of the neutral nitroalkanes to the corresponding aldehydes or ketones with 
production of H2O2 and nitrite. Although cDNA sequence analysis shows that the 
flavoenzyme is a new member of the acyl-CoA dehydrogenase (ACAD) superfamily. 
NAO does not bind or turnover acyl-CoA substrates. In contrast to ACADs, NAO also 
follows a different reaction mechanism and forms a stable N5 covalent adduct during the 
catalytic cycle. Biochemical modifications of NAO suggested the presence of Cys397, 
Tyr398, Asp402 and Arg in the active site but the specific role of these residues in the 
active site could not be determined because of the lack of three dimensional structure of 
the enzyme (Gadda et al., 2000a; Gadda et al., 2000b; Gadda et al., 2001; Valley & 
Fitzpatrick, 2003a). Crystal structure studies of NAO in different reaction states provide 
insights into the active site architecture, substrate binding channel, and possible reasons 
for relative stability of N5-FAD adduct in the enzyme versus the solution state. 
 
The bottlenecks in solving the crystal structures of NAO were several-fold and have 
been described and discussed throughout this thesis. Conventionally, in protein 
crystallography, getting good diffraction quality crystals is a major impediment; but in 
the case of NAO, crystals were obtained in a relatively short period of time.  NAO was 
crystallized in four different space groups, but the highest diffraction quality crystals had 
an exceptionally long cell edge. In addition to the long cell edge, phasing of the protein 
was a challenging crystallographic problem and took significant computational efforts.  
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The structure of ES*, the N5 covalent adduct of NAO, was solved to 2.2 Å resolution 
using phases calculated from location of 52 SeMet sites. To our knowledge, this is the 
first crystal structure of a flavoprotein trapped during turnover of authentic substrates as a 
covalent adduct at N5-FAD. We also solved the structure of oxidized NAO to 2.07 Å 
resolution. The asymmetric unit has 1.5 homotetramers out of which only four active 
sites are occupied with a weak inhibitor, spermine. Together, these structures provide 
insights into: a) substrate preference and access to the FAD, b) the reaction mechanism, 
and c) the features that differentiate NAO from the structural but not the functional 
homologs in the ACAD family.  
 
The structure of the ES* complex shows clearly resolved electron density for the 
2-nitrobutyl moiety at the N5 position of the isoalloxazine ring. The observation of an 
N5- adduct also supports the carbanion reaction mechanism for NAO.  The isoalloxazine 
ring of the flavin forms numerous hydrogen bonding interactions, which are suggested to 
play an important role in adduct stabilization in the active site of the protein. A 
delocalized negative charge between N1 and O2 positions of the isoalloxazine ring is 
stabilized via hydrogen bonding interactions with the side chain of Ser134 and amide 
protons on the nitrogen atoms of Ser134 and His133, respectively. The nitro group of the 
adduct forms hydrogen bond with OD2 of the Asp402. Asp402 further forms hydrogen 
bond and ionic interaction with Arg409. The N3 and N5 of the isoalloxazine ring are 
hydrogen bonded to O of Leu131 and OG of Ser171, respectively.  
 
The structure of the EI complex of NAO reveals a substrate access channel that 
terminates at the N5 atom of the flavin. In ACADs, the N5 cavity is not accessible from 
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the exterior of the protein and the substrates bind to the active site via N1 substrate access 
channel. Nitroalkane oxidase, in contrast to its ACAD homologs, has sterically occluded 
N1 channel so that the substrates access the active site via N5 channel. The N1 cavity in 
NAO also has missing hydrogen bond donors and acceptors, which are critical for proper 
positioning of the acyl-CoA substrates in ACADs. Although NAO and ACADs belong to 
the same superfamily, the differences in the substrate channel explain the observation that 
they do not cross react. The terminal nitrogen of the spermine forms a hydrogen bond 
with the 2’OH of the ribityl chain of FAD, which is similar to the hydrogen bond 
between the carbonyl oxygen of the thioester substrate and 2’ OH of the flavin ribityl 
chain in case of ACADs. This particular hydrogen bond is critical for lowering the pKa of 
the substrates in ACADs and is suggested to have a similar role in NAO. Asp402 is the 
active site base in NAO, whereas in ACADs the analog is Glu376. The electrostatic 
interactions between Lys359 and the residues of active site J-K loop are conserved in all 
the members of ACAD superfamily, except for iso-valeryl acyl-CoA dehydrogenase 
(ICAD). In ICAD, a similar role is played by Arg381 despite the fact that the active site 
base is not located on the J-K loop. The crystal structural studies of NAO suggest that 
NAO and ACADs diverged sufficiently from a common ancestor to support different 
substrate specificity and reaction mechanism. 
 
The structural overlay of ES* and EI revealed significant movement in the side 
chain of Asp402 (1.26 Å). The side chain movement is suggested to help in α-proton 
abstraction from the substrate. The side chain conformation of Asp402 in NAO subunits 
is coupled to orientation of Ser276 side chain. Most of the large r.m.s.d. shifts between 
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the Eox, EI, and ES* crystal structures are observed for the residues, which are far away 
from the active site and are located on the protein surface. For example, the protein 
backbone and side chains of Glu 342 and Glu344, which are present at the mouth of N5 
channel, have main chain r.m.s.d. of ~0.76 Å and side chain r.m.s.d. of ~2.2 Å. 
 
The crystal structures of EI and ES* reveal that the protein backbone packs tightly 
against the si-face of the flavin in NAO. Thus, the formation of C4a-peroxy adduct of 
FAD is sterically occluded on the si-face. The structural overlap of the hypothetical 
model of C4a-hydroperoxide adduct of FAD and the active site FAD in NAO shows that 
re-face of the flavin has sufficient volume to allow C4a peroxy formation. Since the N5 
position is blocked in ES* and si-face is sterically occluded for C4a peroxy formation, 
the adduct exhibits resistance towards O2 reactivity. To conclude, NAO crystal structures 
have helped in defining a structural basis for the observed biochemical properties of 
NAO. The knowledge of structures will also be useful in designing the future studies on 









7 FUTURE DIRECTIONS 
 
The goal of this thesis was to solve the three dimensional structure of NAO and its 
different reaction intermediates. The structural comparison of Eox, EI and ES* reveal 
significant differences in the conformation of the active site residues, which suggest their 
role in substrate specificity, reaction mechanism and N5-adduct stabilization. The 
specific functional role of these residues needs to be further evaluated through 
mutagenesis and crystallographic studies.  
 
Nitroalkane oxidase is a unique flavoenzyme in many aspects. One of the 
characteristic features of the resting state of the enzyme is its selectivity towards neutral 
nitroalkane. In contrast, the cationic imine formed during the catalytic cycle does react 
with nitronates to form stable N5-adduct (Valley et al., 2005). The kinetic analysis of 
D402A mutant shows that enzyme activity can be rescued with the deprotonated substrate 
(Valley & Fitzpatrick, 2003a). This suggests that a negative charge on Asp402 in the 
resting state of the enzyme could inhibit the nitronates from binding the active site. It will 
be interesting to study the crystal structures of D402A mutant in complex with NAO 
inhibitors like benzoate or valarate to determine whether negatively charged substrates 
still bind via N5 channel or if they bind in N1 channel that has a positively charged 
guanidinio group from Arg409. Although the N1 channel in NAO has the largest volume, 
the active site access through this channel is sterically restricted because of Phe273. 
Different mutants of Phe273 will help in studying substrate binding possibilities through 
the N1 channel. Site directed mutagenesis and crystallographic analysis of Leu99, 
Leu131, His133, Ser134, Trp169, Ser171, Phe273, Asp402, Arg409 mutants will shed 
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more light on how the active site environment might help in the stabilization of N5-
adduct. 
  
The crystal structures of NAO also form the basis for directed evolution studies. 
Although the overall protein fold of NAO is similar to ACADs, there are differences in 
the active site residues and in the residues lining the substrate channel. This observation 
along with cDNA analysis, which identified NAO as a member of ACAD superfamily 
(Daubner et al., 2002), suggest that NAO and ACADs have diverged from a common 
ancestor to carry out different reactions. Structural overlays of NAO with ACAD 
homologs suggest that residues like Gln61, Ala98, Ala140, Ala205, Phe273, Ala274, 
Ser276, Ala277, Asp 402, Leu408, and Arg415 are likely to define NAO substrate 
specificity. Kinetic studies of these mutants can help in studying the natural process of 
evolution at the laboratory level. It will be also interesting to see if any of these mutants 
will act as NAO-ACAD chimeras and strengthen the evolutionary link between NAO and 
other ACAD homologs. 
 
Future studies could also be focused on understanding the role of FAD in the NAO 
reaction mechanism. Flavins are versatile redox centers, which depending on their redox 
potential, will either accept or donate electrons. The redox potential of the flavins is 
largely determined by the protein environment (Massey, 2000). In different structures of 
NAO, we observe large shifts in the side chain conformations of Asn172 and Asn405. It 
is interesting to know that active site asparagines are the characteristic feature of 
flavoproteins like flavodoxin from Helicobacter pylori (Freigang et al., 2002), 
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cholesterol oxidase (Sampson, 2001) and choline oxidase (Lountos et al., unpublished 
work) etc. The Asn mutants of flavodoxins and cholesterol oxidase have suggested that 
asparagines play an important role in controlling the redox potential of flavins (Yin et al., 
2001; Carr et al., 1990). Although Asn172 and Asn405 in NAO are about ~6 Å away 
from the isoalloxazine ring, single mutant studies will provide insights into their potential 
role in NAO. The knowledge of the active site residues and their interaction with FAD 
can also be used to modify NAO chemistry. For example, in the case of NAO, the ribityl 
chain of the FAD forms some unique hydrogen bond interactions that are not present in 
other homologs. The differences in the hydrogen bonding pattern is suggested to play an 
important role in defining the active site environment of NAO. The role of particular 
hydrogen bond interactions in the reaction mechanism can be evaluated by use of deoxy-
flavins. 
 
The scope of the NAO crystal structures is not limited to protein crystallography or 
protein biochemistry, but the structural knowledge can also be applied in designing better 
biocatalysts for bioremediation, in making biosensors that can sense different nitro 
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